0000785557false2024Q3September 30xbrli:sharesiso4217:USDxbrli:sharesiso4217:USDdlhc:subleasedlhc:sublease_optionxbrli:pure00007855572023-10-012024-06-3000007855572024-07-3000007855572024-04-012024-06-3000007855572023-04-012023-06-3000007855572022-10-012023-06-3000007855572024-06-3000007855572023-09-3000007855572022-09-3000007855572023-06-300000785557us-gaap:CommonStockMember2023-09-300000785557us-gaap:AdditionalPaidInCapitalMember2023-09-300000785557us-gaap:RetainedEarningsMember2023-09-300000785557us-gaap:AdditionalPaidInCapitalMember2023-10-012024-06-300000785557us-gaap:CommonStockMember2023-10-012024-06-300000785557us-gaap:RetainedEarningsMember2023-10-012024-06-300000785557us-gaap:CommonStockMember2024-06-300000785557us-gaap:AdditionalPaidInCapitalMember2024-06-300000785557us-gaap:RetainedEarningsMember2024-06-300000785557us-gaap:CommonStockMember2024-03-310000785557us-gaap:AdditionalPaidInCapitalMember2024-03-310000785557us-gaap:RetainedEarningsMember2024-03-3100007855572024-03-310000785557us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300000785557us-gaap:CommonStockMember2024-04-012024-06-300000785557us-gaap:RetainedEarningsMember2024-04-012024-06-300000785557us-gaap:CommonStockMember2022-09-300000785557us-gaap:AdditionalPaidInCapitalMember2022-09-300000785557us-gaap:RetainedEarningsMember2022-09-300000785557us-gaap:CommonStockMember2022-10-012023-06-300000785557us-gaap:AdditionalPaidInCapitalMember2022-10-012023-06-300000785557us-gaap:RetainedEarningsMember2022-10-012023-06-300000785557us-gaap:CommonStockMember2023-06-300000785557us-gaap:AdditionalPaidInCapitalMember2023-06-300000785557us-gaap:RetainedEarningsMember2023-06-300000785557us-gaap:CommonStockMember2023-03-310000785557us-gaap:AdditionalPaidInCapitalMember2023-03-310000785557us-gaap:RetainedEarningsMember2023-03-3100007855572023-03-310000785557us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000785557us-gaap:CommonStockMember2023-04-012023-06-300000785557us-gaap:RetainedEarningsMember2023-04-012023-06-300000785557srt:MinimumMember2024-06-300000785557srt:MaximumMember2024-06-300000785557dlhc:OmnibusEquityIncentivePlan2016Memberus-gaap:EmployeeStockOptionMember2023-10-012024-06-300000785557us-gaap:CustomerConcentrationRiskMemberdlhc:DepartmentofHealthandHumanServicesMemberus-gaap:RevenueFromContractWithCustomerMember2024-04-012024-06-300000785557us-gaap:CustomerConcentrationRiskMemberdlhc:DepartmentofHealthandHumanServicesMemberus-gaap:RevenueFromContractWithCustomerMember2023-04-012023-06-300000785557us-gaap:CustomerConcentrationRiskMemberdlhc:DepartmentofHealthandHumanServicesMemberus-gaap:RevenueFromContractWithCustomerMember2023-10-012024-06-300000785557us-gaap:CustomerConcentrationRiskMemberdlhc:DepartmentofHealthandHumanServicesMemberus-gaap:RevenueFromContractWithCustomerMember2022-10-012023-06-300000785557dlhc:DepartmentOfVeteransAffairsMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2024-04-012024-06-300000785557dlhc:DepartmentOfVeteransAffairsMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-04-012023-06-300000785557dlhc:DepartmentOfVeteransAffairsMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-10-012024-06-300000785557dlhc:DepartmentOfVeteransAffairsMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2022-10-012023-06-300000785557us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberdlhc:DepartmentOfDefenseMember2024-04-012024-06-300000785557us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberdlhc:DepartmentOfDefenseMember2023-04-012023-06-300000785557us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberdlhc:DepartmentOfDefenseMember2023-10-012024-06-300000785557us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberdlhc:DepartmentOfDefenseMember2022-10-012023-06-300000785557us-gaap:CustomerConcentrationRiskMemberdlhc:OtherCustomersMemberus-gaap:RevenueFromContractWithCustomerMember2024-04-012024-06-300000785557us-gaap:CustomerConcentrationRiskMemberdlhc:OtherCustomersMemberus-gaap:RevenueFromContractWithCustomerMember2023-04-012023-06-300000785557us-gaap:CustomerConcentrationRiskMemberdlhc:OtherCustomersMemberus-gaap:RevenueFromContractWithCustomerMember2023-10-012024-06-300000785557us-gaap:CustomerConcentrationRiskMemberdlhc:OtherCustomersMemberus-gaap:RevenueFromContractWithCustomerMember2022-10-012023-06-300000785557us-gaap:TimeAndMaterialsContractMember2024-04-012024-06-300000785557us-gaap:TimeAndMaterialsContractMember2023-04-012023-06-300000785557us-gaap:TimeAndMaterialsContractMember2023-10-012024-06-300000785557us-gaap:TimeAndMaterialsContractMember2022-10-012023-06-300000785557dlhc:CostReimbursableContractMember2024-04-012024-06-300000785557dlhc:CostReimbursableContractMember2023-04-012023-06-300000785557dlhc:CostReimbursableContractMember2023-10-012024-06-300000785557dlhc:CostReimbursableContractMember2022-10-012023-06-300000785557us-gaap:FixedPriceContractMember2024-04-012024-06-300000785557us-gaap:FixedPriceContractMember2023-04-012023-06-300000785557us-gaap:FixedPriceContractMember2023-10-012024-06-300000785557us-gaap:FixedPriceContractMember2022-10-012023-06-300000785557us-gaap:SalesChannelDirectlyToConsumerMember2024-04-012024-06-300000785557us-gaap:SalesChannelDirectlyToConsumerMember2023-04-012023-06-300000785557us-gaap:SalesChannelDirectlyToConsumerMember2023-10-012024-06-300000785557us-gaap:SalesChannelDirectlyToConsumerMember2022-10-012023-06-300000785557us-gaap:SalesChannelThroughIntermediaryMember2024-04-012024-06-300000785557us-gaap:SalesChannelThroughIntermediaryMember2023-04-012023-06-300000785557us-gaap:SalesChannelThroughIntermediaryMember2023-10-012024-06-300000785557us-gaap:SalesChannelThroughIntermediaryMember2022-10-012023-06-300000785557srt:MinimumMemberdlhc:FacilitiesAndEquipmentMember2024-06-300000785557dlhc:FacilitiesAndEquipmentMembersrt:MaximumMember2024-06-300000785557us-gaap:CustomerRelationshipsMember2024-06-300000785557us-gaap:CustomerRelationshipsMember2023-09-300000785557us-gaap:NoncompeteAgreementsMember2024-06-300000785557us-gaap:NoncompeteAgreementsMember2023-09-300000785557us-gaap:TradeNamesMember2024-06-300000785557us-gaap:TradeNamesMember2023-09-300000785557dlhc:BacklogMember2024-06-300000785557dlhc:BacklogMember2023-09-300000785557us-gaap:SecuredDebtMember2024-06-300000785557us-gaap:SecuredDebtMember2023-09-300000785557us-gaap:RevolvingCreditFacilityMember2024-06-300000785557us-gaap:RevolvingCreditFacilityMember2023-09-300000785557us-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMember2024-06-300000785557us-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMember2023-10-012024-06-300000785557us-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMember2023-09-300000785557us-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMember2022-10-012023-09-300000785557us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredDebtMember2024-06-300000785557us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredDebtMember2023-10-012024-06-300000785557us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredDebtMember2023-09-300000785557us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredDebtMember2022-10-012023-09-300000785557dlhc:InterestRateSwapDue2026Member2024-06-300000785557us-gaap:InterestRateSwapMember2024-04-012024-06-300000785557us-gaap:InterestRateSwapMember2023-10-012024-06-300000785557srt:MaximumMemberus-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMember2023-10-012024-06-300000785557srt:MinimumMemberus-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMember2023-10-012024-06-300000785557us-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMemberdlhc:ExcessCashFlowsGreaterThanOrEqualto2.50Member2023-10-012024-06-300000785557dlhc:ExcessCashFlowsLessThan2.50ButGreaterThan1.50Memberus-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMember2023-10-012024-06-300000785557dlhc:ExcessCashFlowsLessThan250Memberus-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMember2023-10-012024-06-300000785557us-gaap:MediumTermNotesMemberdlhc:ExcessCashFlowsEqualto1.50Memberus-gaap:SecuredDebtMember2023-10-012024-06-300000785557dlhc:ExcessCashFlowsLessThan1.50Memberus-gaap:MediumTermNotesMemberus-gaap:SecuredDebtMember2023-10-012024-06-300000785557us-gaap:StandbyLettersOfCreditMemberus-gaap:SecuredDebtMember2024-06-300000785557dlhc:OmnibusEquityIncentivePlan2016Member2024-06-300000785557dlhc:DLHEmployeesMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-04-012024-06-300000785557dlhc:DLHEmployeesMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-012023-06-300000785557dlhc:DLHEmployeesMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-10-012024-06-300000785557dlhc:DLHEmployeesMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-10-012023-06-300000785557us-gaap:SellingGeneralAndAdministrativeExpensesMemberdlhc:NonemployeeDirectorsMember2024-04-012024-06-300000785557us-gaap:SellingGeneralAndAdministrativeExpensesMemberdlhc:NonemployeeDirectorsMember2023-04-012023-06-300000785557us-gaap:SellingGeneralAndAdministrativeExpensesMemberdlhc:NonemployeeDirectorsMember2023-10-012024-06-300000785557us-gaap:SellingGeneralAndAdministrativeExpensesMemberdlhc:NonemployeeDirectorsMember2022-10-012023-06-300000785557us-gaap:RestrictedStockUnitsRSUMember2023-10-012024-06-300000785557us-gaap:RestrictedStockUnitsRSUMember2022-10-012023-06-300000785557us-gaap:RestrictedStockUnitsRSUMemberdlhc:NamedExecutiveOfficerMember2024-04-012024-06-300000785557us-gaap:RestrictedStockUnitsRSUMemberdlhc:NamedExecutiveOfficerMember2023-04-012023-06-300000785557us-gaap:RestrictedStockUnitsRSUMemberdlhc:NamedExecutiveOfficerMember2023-10-012024-06-300000785557us-gaap:RestrictedStockUnitsRSUMemberdlhc:NamedExecutiveOfficerMember2022-10-012023-06-300000785557us-gaap:PerformanceSharesMemberdlhc:NamedExecutiveOfficerMember2023-10-012024-06-300000785557dlhc:ServiceBasedRestrictedStockUnitsMemberdlhc:NamedExecutiveOfficerMember2023-10-012024-06-300000785557us-gaap:PerformanceSharesMemberdlhc:NamedExecutiveOfficerMember2022-10-012023-06-300000785557dlhc:ServiceBasedRestrictedStockUnitsMemberdlhc:NamedExecutiveOfficerMember2022-10-012023-06-300000785557us-gaap:RestrictedStockUnitsRSUMemberdlhc:NonemployeeDirectorsMember2024-04-012024-06-300000785557us-gaap:RestrictedStockUnitsRSUMemberdlhc:NonemployeeDirectorsMember2023-04-012023-06-300000785557dlhc:PerformanceBasedRestrictedStockAwardsRevenueMemberdlhc:December152023Member2022-10-012023-06-300000785557dlhc:PerformanceBasedRestrictedStockAwardsRevenueMemberdlhc:December152023Member2023-10-012024-06-300000785557dlhc:December152023Member2023-10-012024-06-300000785557dlhc:December152023Member2022-10-012023-06-300000785557dlhc:PerformanceBasedRestrictedStockAwardsStockPriceMemberdlhc:December152023Member2023-10-012024-06-300000785557dlhc:PerformanceBasedRestrictedStockAwardsStockPriceMemberdlhc:December152023Member2022-10-012023-06-300000785557dlhc:PerformanceBasedRestrictedStockAwardsRevenueMemberdlhc:January272023Member2022-10-012023-06-300000785557dlhc:PerformanceBasedRestrictedStockAwardsRevenueMemberdlhc:January272023Member2023-10-012024-06-300000785557dlhc:January272023Member2022-10-012023-06-300000785557dlhc:January272023Member2023-10-012024-06-300000785557dlhc:January272023Memberdlhc:PerformanceBasedRestrictedStockAwardsStockPriceMember2022-10-012023-06-300000785557dlhc:January272023Memberdlhc:PerformanceBasedRestrictedStockAwardsStockPriceMember2023-10-012024-06-300000785557dlhc:DLHEmployeesMember2024-06-300000785557dlhc:DLHEmployeesMember2023-06-300000785557dlhc:NonemployeeDirectorsMember2024-06-300000785557dlhc:NonemployeeDirectorsMember2023-06-300000785557dlhc:DLHEmployeesMember2023-10-012024-06-3000007855572022-10-012023-09-300000785557dlhc:FacilityLeasesMember2024-06-30


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
For the quarterly period ended June 30, 2024
 
         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
For the transition period from                        to
 
Commission File No. 0-18492
 
DLH HOLDINGS CORP.
(Exact name of registrant as specified in its charter)
New Jersey 22-1899798
(State or other jurisdiction of
 incorporation or organization)
(I.R.S. Employer
Identification No.)
3565 Piedmont Road,Building 3, Suite 700 30305
Atlanta, Georgia
(Zip code)
(Address of principal executive offices)
(770) 554-3545
(Registrant’s telephone number, including area code)

Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common StockDLHCNasdaqCapital Market
  
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes      No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes    No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller Reporting Company
 Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes   No ý
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 14,182,891 shares of Common Stock, par value $0.001 per share, were outstanding as of July 30, 2024.












DLH HOLDINGS CORP.
FORM 10-Q
 

TABLE OF CONTENTS
Page No.
2



PART I FINANCIAL INFORMATION

ITEM I: FINANCIAL STATEMENTS (UNAUDITED)


DLH HOLDINGS CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited, in thousands, except per share amounts)
Three Months EndedNine Months Ended
 June 30,June 30,
 2024202320242023
Revenue$100,694 $102,241 $299,551 $274,385 
Cost of operations:
Contract costs81,646 80,919 239,839 216,779 
General and administrative costs9,013 9,935 28,420 27,670 
Corporate development costs   1,735 
Depreciation and amortization4,272 4,280 12,769 11,281 
Total operating costs94,931 95,134 281,028 257,465 
Income from operations5,763 7,107 18,523 16,920 
Interest expenses
4,143 4,917 12,991 11,512 
Income before provision for income tax1,620 2,190 5,532 5,408 
Provision for income tax expense481 452 430 1,318 
Net income$1,139 $1,738 $5,102 $4,090 
Net income per share - basic$0.08 $0.13 $0.36 $0.30 
Net income per share - diluted$0.08 $0.12 $0.35 $0.28 
Weighted average common stock outstanding
Basic14,232 13,854 14,156 13,638 
Diluted14,704 14,539 14,716 14,421 
 
The accompanying notes are an integral part of these consolidated financial statements.
3



DLH HOLDINGS CORP.
CONSOLIDATED BALANCE SHEETS
(in thousands, except par value of shares) 
June 30,
2024
September 30,
2023
(unaudited)
ASSETS  
Current assets:  
Cash$423 $215 
Accounts receivable58,341 59,119 
Other current assets2,742 3,067 
Total current assets61,506 62,401 
Goodwill138,161 138,161 
Intangible assets, net112,435 124,777 
Operating lease right-of-use assets7,498 9,656 
Deferred taxes, net3,381 3,070 
Equipment and improvements, net1,790 1,590 
Other long-term assets186 186 
Total assets$324,957 $339,841 
LIABILITIES AND SHAREHOLDERS’ EQUITY  
Current liabilities:  
Accounts payable and accrued liabilities$23,189 $29,704 
Debt obligations - current, net of deferred financing costs17,646 17,188 
Accrued payroll14,232 13,794 
Operating lease liabilities - current2,889 3,463 
Other current liabilities482 638 
Total current liabilities58,438 64,787 
Long-term liabilities:
Debt obligations - long-term, net of deferred financing costs143,258 155,147 
Operating lease liabilities - long-term13,521 15,908 
Other long-term liabilities1,135 1,560 
Total long-term liabilities157,914 172,615 
Total liabilities216,352 237,402 
Shareholders' equity:
Common stock, $0.001 par value; 40,000 shares authorized; 14,183 and 13,950 shares issued and outstanding at June 30, 2024 and September 30, 2023, respectively
14 14 
Additional paid-in capital101,038 99,974 
Retained earnings7,553 2,451 
Total shareholders’ equity108,605 102,439 
Total liabilities and shareholders' equity$324,957 $339,841 


 The accompanying notes are an integral part of these consolidated financial statements.
4



DLH HOLDINGS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in thousands) 
Nine Months Ended
June 30,
 20242023
Operating activities  
Net income$5,102 $4,090 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization12,769 11,281 
Amortization of deferred financing costs charged to interest expense1,437 1,540 
Stock-based compensation expense2,290 2,020 
Deferred taxes, net(311) 
Changes in operating assets and liabilities: 
Accounts receivable778 (1,918)
Other assets2,484 130 
Accounts payable and accrued liabilities(6,515)(4,221)
Accrued payroll437 274 
Other liabilities(3,540)1,801 
Net cash provided by operating activities14,931 14,997 
Investing activities  
Business acquisition, net of cash acquired (180,711)
Purchase of equipment and improvements(627)(580)
Net cash (used in) investing activities
(627)(181,291)
Financing activities  
Proceeds from revolving line of credit257,067 144,697 
Repayment of revolving line of credit(252,123)(128,204)
Proceeds from debt obligations 168,000 
Repayments of debt obligations(17,813)(10,688)
Payments of deferred financing costs (7,666)
Proceeds from issuance of common stock upon exercise of options and warrants261 1,107 
Payment of tax obligations resulting from net exercise of stock options(1,488)(650)
Net cash (used in) provided by financing activities(14,096)166,596 
Net change in cash208 302 
Cash - beginning of period215 228 
Cash - end of period$423 $530 
Supplemental disclosure of cash flow information  
Cash paid during the period for interest$11,656 $10,006 
Cash paid during the period for income taxes$2,280 $4,055 
Supplemental disclosure of non-cash activity
Common stock surrendered for the exercise of stock options$2,432 $238 

The accompanying notes are an integral part of these consolidated financial statements.
5



DLH HOLDINGS CORP.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(unaudited, in thousands, except for per share data) 
Common StockAdditional
Paid-In
Capital
Retained Earnings
Total Shareholders' Equity
SharesAmount
Balance at September 30, 2023
13,950$14 $99,974 $2,451 $102,439 
Expense related to director restricted stock units— — 439 — 439 
Expense related to employee stock-based compensation— — 1,851 — 1,851 
Exercise of stock options535— 261 — 261 
Common stock surrendered for the exercise of stock options(302)— (1,487)— (1,487)
Net income— — — 5,102 5,102 
Balance at June 30, 2024
14,183$14 $101,038 $7,553 $108,605 
Balance at March 31, 2024
14,230$14 $100,322 $6,414 $106,750 
Expense related to director restricted stock units— — 180 — 180 
Expense related to employee stock-based compensation— — 537 — 537 
Common stock surrendered for the exercise of stock options(47)— (1)— (1)
Net income— — — 1,139 1,139 
Balance at June 30, 2024
14,183$14 $101,038 $7,553 $108,605 
Common StockAdditional
Paid-In
Capital
Retained Earnings
Total Shareholders' Equity
SharesAmount
Balance at September 30, 2022
13,047$13 $91,057 $990 $92,060 
Issuance and fair value adjustment of common stock in business combination5271 6,538 — 6,539 
Expense related to director restricted stock units— — 539 — 539 
Expense related to employee stock-based compensation— — 1,481 — 1,481 
Exercise of stock options393— 1,107 — 1,107 
Common stock surrendered for the exercise of stock options(67)— (650)— (650)
Net income— — — 4,090 4,090 
Balance at June 30, 2023
13,900 $14 $100,072 $5,080 $105,166 
Balance at March 31, 2023
13,793$14 $98,584 $3,342 $101,940 
Expense related to director restricted stock units— — 179 — 179 
Expense related to employee stock-based compensation— — 489 — 489 
Exercise of stock options107— 820 — 820 
Net income— — — 1,738 1,738 
Balance at June 30, 2023
13,900 $14 $100,072 $5,080 $105,166 
The accompanying notes are an integral part of these consolidated financial statements.

6



DLH HOLDINGS CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
June 30, 2024

1. Basis of Presentation and Principles of Consolidation

The accompanying consolidated financial statements include the accounts of DLH Holdings Corp. and its wholly-owned subsidiaries (together with its subsidiaries, "DLH" or the "Company" and also referred to as "we," "us" and "our"). All significant intercompany balances and transactions have been eliminated in consolidation. The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, these statements do not include all of the information and footnotes required by GAAP for complete financial statements.

Operating results for the nine months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the year ending September 30, 2024 or any future period. Amounts as of June 30, 2024 and for the three and nine months ended June 30, 2024 are unaudited. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2023 filed with the Securities and Exchange Commission on December 6, 2023.


2. Significant Accounting Policies

Use of Estimates
 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The most significant of these estimates and assumptions relate to estimating costs including overhead and its allocation, valuing and determining the amortization periods for long-lived intangible assets, interest rate swaps, stock-based compensation, and right-of-use assets and lease liabilities. We evaluate these estimates and judgments on an ongoing basis and base our estimates on historical experience, current and expected future outcomes, third-party evaluations, and various other assumptions that we believe are reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities as well as identifying and assessing the accounting treatment with respect to commitments and contingencies. We revise material accounting estimates if changes occur, such as more experience is acquired, additional information is obtained, or there is new information on which an estimate was or can be based. Actual results could differ from those estimates.

Revenue

The Company's revenues from contracts with customers are derived from offerings that include technology-enabled business process outsourcing, program management solutions, and public health research and analytics, substantially within the U.S. government and its agencies. The Company has various types of contracts including time-and-materials contracts, cost-reimbursable contracts, and firm-fixed-price contracts.

We consider a contract with a customer to exist when there is a commitment by both parties (customer and Company), payment terms are determinable, there is commercial substance, and collectability is probably in accordance with Accounting Standards Codification ("ASC") No. 606, "Revenue from Contracts with Customers" ("Topic 606").

We recognize revenue over time when there is a continuous transfer of control to our customer as performance obligations are satisfied. For our U.S. government contracts, this continuous transfer of control to the customer is transferred over time and revenue is recognized based on the extent of progress toward completion of the performance obligation. We consider control to transfer when we have a right to payment. In some instances, the Company commences providing services prior to formal approval to begin work from the customer. The Company considers these factors, the risks associated with commencing work, and legal enforceability in determining whether a contract exists under Topic 606.

Contract modification can occur throughout the life of the contract and can affect the transaction price, extend the period of performance, adjust funding, or create new performance obligations. We review each modification to assess the impact of these contract changes to determine if it should be treated as part of the original performance obligation or as a separate contract.
7



Contract modifications impact performance obligations when the modification either creates new or changes the existing enforceable rights and obligations. The effect of a contract modification on the transaction price and our measure of progress for the performance obligation to which it relates is recognized as an adjustment to revenue and profit cumulatively. Furthermore, a significant change in one or more estimates could affect the profitability of our contracts. We recognize adjustments in estimated profit on contracts in the period identified.

For service contracts, we satisfy our performance obligations as services are rendered. We use cost-based input and time-based output methods to measure progress based on the contract type.

Time and material - We bill the customer per labor hour and per material, and revenue is recognized in the amount invoiced as the amount corresponds directly to the value of our performance to date. Revenue is recognized to the extent of billable rates times hours delivered plus materials and other reimbursable costs incurred.
Cost reimbursable - We record reimbursable costs as incurred, including an estimated share of the contractual fee earned.
Firm fixed price - We recognize revenue over time using a straight-line measure of progress.

Contract costs generally include direct costs such as labor, materials, subcontract costs, and indirect costs identifiable with or allocable to a specific contract. Costs are expensed as incurred and include an estimate of the contractual fees earned. Contract costs incurred for U.S. government contracts, including indirect costs, are subject to audit and adjustment by various government audit agencies. Historically, our adjustments have not been material.

Contract assets - Amounts are invoiced as work progresses in accordance with agreed-upon contractual terms. In part, revenue recognition occurs before we have the right to bill, resulting in contract assets. These contract assets are reported within accounts receivable on our consolidated balance sheets and are invoiced in accordance with payment terms defined in each contract. Period end balances will vary from period to period due to agreed-upon contractual terms.

Fair Value of Financial Instruments
 
The carrying amounts of the Company's cash, accounts receivable, contract assets, accrued expenses, and accounts payable approximate fair value due to the short-term nature of these instruments. The fair values of the Company's debt instruments approximate fair value because the underlying interest rates approximate market rates that the Company could obtain for similar instruments at the balance sheet dates.

Long-Lived Assets

Our long-lived assets include equipment and improvements, intangible assets, right-of-use assets, and goodwill. The Company continues to review long-lived assets for possible impairment or loss of value at least annually, or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit's carrying amount is greater than its fair value.

Equipment and improvements are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful asset lives (3 to 7 years) and the shorter of the initial lease term or estimated useful life for leasehold improvements. Maintenance and repair costs are expensed as incurred. Intangible assets (other than goodwill) are originally recorded at fair value and are amortized on a straight-line basis over their estimated useful lives of 10 years.

Right-of-use assets are measured at the present value of future minimum lease payments, including all probable renewals, plus lease payments made to the lessor before or at lease commencement and indirect costs paid, less incentives received. Our right-of-use assets include long-term leases for facilities and equipment and are amortized over their respective lease terms.

8



Lease Liabilities

The Company has leases for facilities and office equipment. Our lease liabilities are recognized as the present value of the future minimum lease payments over the lease term. Our lease payments consist of fixed and in-substance fixed amounts attributable to the use of the underlying asset over the lease term. Variable lease payments that do not depend on an index rate or are not in-substance fixed payments are excluded in the measurement of right-of-use assets and lease liabilities and are expensed in the period incurred. The incremental borrowing rate on our secured term loan is used in determining the present value of future minimum lease payments. Some of our lease agreements include options to extend the lease term or terminate the lease. These options are accounted for in our right-of-use assets and lease liabilities when it is reasonably certain that the Company will extend the lease term or terminate the lease. The Company does not have any finance leases.

Goodwill

The Company reviews goodwill for impairment on an annual basis and on a quarterly basis the Company assesses the impact of any macroeconomic changes that may impact the business conditions to determine if these changes have any adverse impact to goodwill. Notwithstanding this evaluation, factors including non-renewal of a major contract or other substantial changes in business conditions could have a material adverse effect on the valuation of goodwill in future periods and the resulting charge could be material to future periods’ results of operations. The Company determined that no change in business conditions occurred which would have a material adverse effect on the valuation of goodwill.

Income Tax

The Company accounts for income taxes in accordance with the asset and liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reflected on the consolidated balance sheets when it is determined that it is more likely than not that the asset will be realized. This guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax asset will not be realized. We account for uncertain tax positions by recognizing the financial statement effects of a tax position only when, based upon the technical merits, it is more likely than not that the position will be sustained upon examination. We had no uncertain tax positions at either June 30, 2024 or September 30, 2023. We report interest and penalties as a component of provision for income taxes. During the three and nine months ended June 30, 2024 and 2023, we recognized no interest and no penalties related to income taxes.

Stock-Based Compensation

The Company uses the fair value-based method for stock-based compensation. Options issued are designated as either an incentive stock option or a non-statutory stock option. No option may be granted with a term of more than 10 years from the date of grant. Option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued common shares. All awards to employees and non-employees are recorded at fair value on the date of the grant and expensed over the period of vesting. The Company uses a Monte Carlo method to estimate the fair value of each stock option at the date of grant. Any consideration paid by the option holders to purchase shares is credited to common stock.

Stock-based compensation expense for the portion of equity awards for which the requisite service has not been rendered is recognized as the requisite service is rendered. The stock-based compensation expense for that portion of awards has been based on the grant-date fair value of those awards as calculated for recognition purposes under applicable guidance. For options that vest based on the Company’s common stock achieving and maintaining defined market prices, the Company values the awards with a Monte Carlo method that utilizes various probability factors and other criterion in establishing fair value of the grant. The related compensation expense is recognized over the service period.

9



Cash

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. We maintain cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation up to $250,000. Deposits held with financial institutions may exceed the $250,000 limit.

Accounts Receivable

Receivables include amounts billed and currently due from customers where the right to consideration is unconditional and amounts unbilled. Both billed and unbilled amounts are non-interest bearing, unsecured, and recognized at an estimated realizable value that includes costs and fees, and are generally expected to be billed and received within a single year. We evaluate our receivables for expected credit losses on a quarterly basis and determine whether an allowance for expected credit losses is appropriate based on specific collection issues.

Earnings Per Share

Basic earnings per share is calculated by dividing income available to common shareholders by the weighted average number of common stock outstanding and restricted stock grants that vested or are likely to vest during the period. Diluted earnings per share is calculated by dividing income available to common shareholders by the weighted average number of basic common shares outstanding, adjusted to reflect potentially dilutive securities. Diluted earnings per share is calculated using the treasury stock method.

Treasury Stock

The Company periodically purchases its own common stock that is traded on public markets as part of announced stock repurchase programs. The repurchased common stock is classified as treasury stock on the consolidated balance sheets and held at cost. As of June 30, 2024 and September 30, 2023, the Company did not hold any treasury stock.

Preferred Stock

Our certificate of incorporation authorizes the issuance of "blank check" preferred stock with designations, rights and preferences as may be determined from time to time by our board of directors up to an aggregate of 5,000,000 shares of preferred stock. As of June 30, 2024 and September 30, 2023, the Company has not issued any preferred stock.

Interest Rate Swap

The Company uses derivative financial instruments to manage interest rate risk associated with its variable debt. The Company's objective in using these interest rate derivatives is to manage its exposure to interest rate movements and reduce volatility of interest expense. The gains and losses due to changes in the fair value of the interest rate swap agreements completely offset changes in the fair value of the hedged portion of the underlying debt. Offsetting changes in fair value of both the interest rate swaps and the hedged portion of the underlying debt are recognized in interest expense in the consolidated statements of operations. The Company does not hold or issue any derivative instruments for trading or speculative purposes.

Risks and Uncertainties

Management evaluates the impact of global markets and economic factors on our industry and the potential for adverse effects on the Company's consolidated financial position and its operations. As of June 30, 2024 and September 30, 2023 there was no indication of any global or economic impacts to our industry.


3. New Accounting Pronouncements

In November 2023, Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" which provides guidance intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses, and each reported measure of segment profit or loss. The ASU requires that a public entity that has a single reportable segment provide all the disclosures required by the amendments in this ASU and all existing segment disclosures in Topic 280. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2023 and interim
10



periods beginning after December 15, 2024. We are currently evaluating the impacts of the single reportable segment disclosures.

In December 2023, FASB issued ASU 2023-09 "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" which provides guidance on the requirements such as the requirement that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. DLH is a public company that reports income tax disclosures and therefore this ASU applies to the Company. ASU 2023-09 is effective for public business entities for fiscal years beginning after Dec. 15, 2024. We are currently evaluating the impacts of the improvements to income tax disclosure.

In March 2024, FASB issued ASU No. 2024-01, "Scope Application of Profits Interest and Similar Awards". The ASU clarifies how an entity determines whether a profits interest or similar award is (1) within the scope of ASC 718 or (2) not a share-based payment arrangement and therefore within the scope of other guidance. The guidance in ASU 2024-01 applies to all entities that issue profits interest awards as compensation to employees or non-employees in exchange for goods or services. We are currently evaluating the impacts of the improvements to our disclosure.

In March 2024, the Securities and Exchange Commission ("SEC") has released a final rule that requires registrants to provide comprehensive climate-related disclosures in their annual reports and registration statements, including those for IPOs, beginning with annual reports for the year ending December 31, 2027, for smaller reporting companies ("SRC"). Registrants must disclose climate-related financial metrics and impacts on their financial estimates and assumptions in a footnote to the audited financial statements. The disclosures will also need to be addressed as part of management’s internal control over financial reporting ("ICFR") and will be subject to the financial statement and ICFR audit (if applicable) of an independent registered public accounting firm. We are currently evaluating the impacts of the improvements to our disclosure.


4. Revenue Recognition
The following table summarizes the contract balances recognized on the Company's consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Contract assets$23,061 $20,542 

Contract assets are included as part of the accounts receivable on the consolidated balances sheets. Contract liabilities had no balance as of June 30, 2024 and September 30, 2023.

Disaggregation of Revenue from Contracts with Customers

We disaggregate our revenue from contracts with customers by customer, contract type, as well as whether the Company acts as prime contractor or subcontractor. We believe these categories best depict how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. The following series of tables present our revenue disaggregated by these categories:

Revenue by customer was as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Department of Health and Human Services$48,301 $44,536 $139,937 $115,528 
Department of Veterans Affairs35,492 35,898 105,788 104,489 
Department of Defense15,175 21,003 48,458 50,802 
Other1,726 804 5,368 3,566 
Total $100,694 $102,241 $299,551 $274,385 
11




Revenue by contract type was as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Time and Materials$54,978 $51,572 $165,260 $154,366 
Cost Reimbursable19,513 29,110 60,166 58,951 
Firm Fixed Price26,203 21,559 74,125 61,068 
Total $100,694 $102,241 $299,551 $274,385 

Revenue by whether the Company acts as a prime contractor or a subcontractor was as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Prime Contractor$90,791 $97,885 $269,109 $259,692 
Subcontractor9,903 4,356 30,442 14,693 
Total $100,694 $102,241 $299,551 $274,385 


5. Leases

The following table summarizes lease balances presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Operating lease right-of-use assets$7,498 $9,656 
Operating lease liabilities, current$2,889 $3,463 
Operating lease liabilities - long-term13,521 15,908 
Total operating lease liabilities$16,410 $19,371 

As of June 30, 2024, operating leases for facilities and equipment have remaining lease terms of less than 1 year to 7.5 years.

Total lease costs for our leases were as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Operating $883 $1,097 $4,915 $2,921 
Short-term 50 83 298 225 
Variable 37 47 179 63 
Sublease income (a)(67)(71)(339)(214)
Total lease costs$903 $1,156 $5,053 $2,995 

(a) The Company subleases a portion of one of its leased facilities. The sublease is classified as an operating lease with respect to the underlying asset. The sublease term is 5 years and includes two additional 1 year term extension options.
12




The Company's future minimum lease payments as of June 30, 2024 were as follows (in thousands):
Fiscal year ending:
2024 (remaining)$1,108 
20253,572 
20263,350 
20272,751 
20282,602 
Thereafter6,546 
Total future lease payments19,929 
   Less: imputed interest(3,519)
Present value of future minimum lease payments16,410 
   Less: current portion of operating lease liabilities(2,889)
Long-term operating lease liabilities$13,521 
At June 30, 2024, the weighted-average remaining lease term and weighted-average discount rate were 6.0 years and 6.1%, respectively. The calculation of the weighted-average discount rate was determined based on borrowing terms from our secured term loan.

Other information related to our leases for the nine months ended June 30, 2024 and 2023 was as follows (in thousands):
20242023
Cash paid for amounts included in the measurement of lease liabilities$3,233 $3,317 
Lease liabilities arising from obtaining right-of-use assets 2,052 
Other lease information$3,233 $5,369 



6. Supporting Financial Information

Accounts receivable

The following table summarizes accounts receivable presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Billed receivables$35,280 $38,577 
Contract assets23,061 20,542 
Accounts receivable$58,341 $59,119 

13



Other current assets

The following table summarizes other current assets presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Prepaid licenses and other expenses$1,426 $1,330 
Prepaid insurance and benefits856 743 
Other receivables460 994 
Other current assets$2,742 $3,067 
Goodwill

There were no activities in goodwill for the three and nine months ended June 30, 2024. The balance of goodwill was $138,161 as of June 30, 2024 and September 30, 2023.


Intangible assets

The following table summarizes intangible assets, net presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Intangible assets
Customer contracts and related customer relationships$113,622 $113,622 
Covenants not to compete637 637 
Trade name13,034 13,034 
Backlog37,249 37,249 
Total intangible assets164,542 164,542 
Less: accumulated amortization
Customer contracts and related customer relationships(38,455)(29,929)
Covenants not to compete(426)(378)
Trade name(3,162)(2,185)
Backlog(10,064)(7,273)
Total accumulated amortization(52,107)(39,765)
Intangible assets, net$112,435 $124,777 

Amortization expense was $4.1 million and $4.1 million for the three months ended June 30, 2024 and 2023, respectively, and $12.3 million and $10.7 million for the nine months ended June 30, 2024 and 2023, respectively.

As of June 30, 2024, the estimated amortization expense per fiscal year was as follows (in thousands):
Fiscal year ending:
2024 (remaining)$4,114 
202516,456 
202615,722 
202714,694 
202814,694 
Thereafter46,755 
Total amortization expense$112,435 

At June 30, 2024, the weighted-average remaining amortization period in total was 7.6 years. The weighted-average amortization period for customer contracts and related customer relationships, backlog, trade names and covenants not to
14



compete was 7.5 years, 7.8 years, 8.0 years, 5.6 years, respectively.

Equipment and improvements, net

The following table summarizes equipment and improvements, net presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Furniture and equipment$1,824 $1,790 
Computer equipment and software7,072 6,479 
Leasehold improvements1,614 1,614 
Total equipment and improvements10,510 9,883 
Less: accumulated depreciation
(8,720)(8,293)
Equipment and improvements, net$1,790 $1,590 

Depreciation expense was $0.2 million and $0.2 million for the three months ended June 30, 2024 and 2023, respectively; $0.4 million and $0.6 million for the nine months ended June 30, 2024 and 2023, respectively.

Accounts payable and accrued liabilities

The following table summarizes accounts payable and accrued liabilities presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Accounts payable$12,513 $12,603 
Accrued benefits5,111 6,414 
Accrued workers' compensation insurance1,828 2,369 
Accrued bonus and incentive compensation2,282 4,719 
Accrued interest1,241 1,309 
Other accrued expenses214 2,290 
Accounts payable and accrued liabilities$23,189 $29,704 

Accrued payroll

The following table summarizes accrued payroll presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Accrued leave$7,718 $9,621 
Accrued payroll5,277 2,487 
Accrued payroll taxes1,115 1,173 
Accrued severance122 513 
Total accrued payroll
$14,232 $13,794 

15



Debt obligations

The following table summarizes debt obligations presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Secured term loan$152,000 $169,813 
Secured revolving line of credit14,490 9,546 
Less: unamortized deferred financing costs(5,586)(7,024)
Net bank debt obligations160,904 172,335 
Less: current portion of debt obligations, net of deferred financing costs (a)(17,646)(17,188)
Long-term portion of debt obligations, net of deferred financing costs$143,258 $155,147 

As of June 30, 2024, we have satisfied quarterly minimum principal payments on our secured term loan through March 31, 2025.

(a) As of June 30, 2024, the current portion comprises term loan amortization of $4.8 million and the $14.5 million outstanding balance on the secured revolving line of credit, net of $1.6 million of unamortized deferred financing costs.
    
Interest expense

The following table summarizes interest expense presented on our consolidated statements of operations as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Interest expense (a)
$3,756 $4,282 $11,588 $9,972 
Interest income (b)
(10) (34) 
Amortization of deferred financing costs (c)
397 635 1,437 1,540 
Interest expense$4,143 $4,917 $12,991 $11,512 

(a) Interest expense on borrowing.
(b) Interest earned from customer payments received after the due date.
(c) Amortization of expenses related to secured term loan and secured revolving line of credit.


7. Credit Facilities

A summary of our credit facilities as presented on our consolidated balance sheets as follows (in millions):
June 30, 2024September 30, 2023
ArrangementLoan BalanceInterestArrangementLoan BalanceInterest
Secured term loan (a) due December 8, 2027$152,000 
SOFR1 + 4.1%
Secured term loan (a) due December 8, 2027$169,813 
SOFR1 + 4.1%
Secured revolving line of credit (b) due December 8, 2027$14,490 
SOFR1 + 4.1%
Secured revolving line of credit (b) due December 8, 2027$9,546 
SOFR1 + 4.1%
1Secured Overnight Financing Rate ("SOFR") as of June 30, 2024 and September 30, 2023 were 5.3% and 5.3% respectively.
(a) Represents the principal amounts payable on our term loan, which is secured by liens on substantially all of the assets of the Company. The principal of the term loan is payable in quarterly installments with the remaining balance due on December 8, 2027.
16



On January 31, 2023, we executed a floating-to-fixed interest rate swap with FNB which has a notional amount of $80.0 million at June 30, 2024, a fixed interest rate of 4.10% and a maturity date of January 31, 2026. As a result of entering these agreements, for the three and nine months ended June 30, 2024, interest expense has been decreased by approximately $0.3 million and $1.0 million, respectively.

The Credit Agreement requires compliance with a number of financial covenants and contains restrictions on our ability to engage in certain transactions. Among other matters, we must comply with limitations on: granting liens; incurring other indebtedness; maintenance of assets; investments in other entities and extensions of credit; mergers and consolidations; and changes in nature of business. The loan agreement also requires us to comply with certain quarterly financial covenants including: (i) a minimum fixed charge coverage ratio of at least 1.25 to 1.00, and (ii) a total leverage ratio not exceeding the ratio of 4.50:1.00 to 2.00:1.00 through maturity. The total leverage ratio is calculated by dividing the Company's total interest-bearing debt by net income adjusted to exclude (i) interest and other expenses, (ii) provision for income taxes (benefit) expense, if any, (iii) depreciation and amortization, and (iv) non-cash charges, losses or expenses, including stock-based compensation, and (v) non-recurring charges, losses or expenses to include transaction and non-cash equity expense. We are in compliance with all loan covenants and restrictions as of June 30, 2024 and September 30, 2023.

We are required to pay quarterly amortization payments, which commenced in December 2022. The annual amortization amounts are $14.3 million for fiscal year 2024, $19.0 million each for fiscal years 2025 and 2026, and $23.75 million for fiscal year 2027, with the remaining unpaid loan balance due at maturity in December 2027. The quarterly payments are equal installments. The Company made voluntary prepayments of $7.1 million during nine months ended June 30, 2024 bringing the outstanding principal balance on the secured term loan to $152.0 million. We have satisfied the mandatory principal payments through March 31, 2025.

In addition to quarterly payments of the outstanding indebtedness, the loan agreement also requires annual payments of a percentage of excess cash flow, as defined in the loan agreement. The loan agreement states that an excess cash flow recapture payment must be made equal to (a) 75% of the excess cash flow for the immediately preceding fiscal year in which indebtedness to consolidated EBITDA ratio is greater than or equal to 2.5:1; (b) 50% of the excess cash flow for the immediately preceding fiscal year in which the funded indebtedness to consolidated EBITDA Ratio is less than 2.5:1 but greater than or equal to 1.5:1; or (c) 0% of the excess cash flow for the immediately preceding fiscal year in which the funded indebtedness to consolidated EBITDA Ratio is less than 1.5:1. In addition, the Company must make additional mandatory prepayment of amounts outstanding based on proceeds received from asset sales and sales of certain equity securities or other indebtedness. Due to the voluntary prepayment of term debt, there was no excess cash flow payment required. For additional information regarding the schedule of future payment obligations, please refer to Note 10. Commitments and Contingencies.

(b) The secured revolving line of credit has a ceiling of up to $70.0 million; as of June 30, 2024, we had unused borrowing capacity of $24.0 million, which is net of outstanding letters of credit. Borrowing on the secured revolving line of credit is secured by liens on substantially all of the assets of the Company. The Company accessed funds from the secured revolving line of credit during the year, which had a $14.5 million outstanding balance at June 30, 2024. As part of the secured revolving line of credit, the lenders agreed to a sublimit of $10.0 million for letters of credit for the account of the Company, subject to applicable procedures.

8. Stock-Based Compensation and Equity Grants

Stock-based compensation expense
 
Options issued under equity incentive plans were designated as either an incentive stock or a non-statutory stock option. No option was granted with a term of more than 10 years from the date of grant. Exercisability of option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued shares. As of June 30, 2024, there were 0.9 million shares available for grant.

17



Stock-based compensation expense shown in the table below, is recorded in general and administrative expenses in our consolidated statements of operations as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
DLH employees (a)$537 $489 $1,851 $1,481 
Non-employee directors (b)180 179 439 539 
Total stock option expense$717 $668 $2,290 $2,020 

(a) Included in this amount are equity grants of restricted stock units ("RSU") to Executive Officers, which were issued in accordance with the DLH long-term incentive compensation policy in this fiscal year, including both RSU and stock option grants to employees during prior fiscal years. The RSUs issued and outstanding totaled 429,320 and 337,578 shares at June 30, 2024 and 2023, respectively. During the three months ended June 30, 2024 and 2023, there were no grants awarded to Executive Officers. For the nine months ended June 30, 2024 and 2023, the Company granted 169,544 and 197,174 shares of restricted stock units, respectively. During the nine months ended June 30, 2024, 84,773 shares of the RSUs granted have performance-based vesting criteria and the remaining 84,771 shares have service-based vesting criteria. During the nine months ended June 30, 2023, 141,892 shares of the RSUs granted have performance-based vesting criteria and the remaining 55,282 shares have service-based vesting criteria.

The RSUs granted during the nine months ended June 30, 2024 and 2023, were valued as follows using the Monte Carlo Method, and will be amortized over the 3-year measurement period.

(b) Equity grants of RSUs were made in accordance with DLH compensation policy for non-employee directors and a total of 61,525 and 50,367 restricted stock units were issued and outstanding at June 30, 2024 and 2023, respectively. These grants have service-based vesting criteria and vest at the end of this fiscal year.

The fair value of RSUs issued during the nine months ended June 30, 2024 and 2023 is presented in the table below:
Volatility
50%
Grant DatePerformance Vesting BasePerformance Vesting Criteria(Years)Fair Value
December 15, 2023RevenueRevenue increase at the end of the performance period as compared to the year ended September 30, 20233$3.82 
December 15, 2023Stock price
Stock price is at least $25.65 per share average for the 30 days prior to the end of the performance period
3$5.36 
January 27, 2023RevenueRevenue increase at the end of the performance period as compared to the year ended September 30, 20223$3.51 
January 27, 2023Stock price
Stock price is at least $33.21 per share average for the 30 days prior to the end of the performance period
3$2.92 
Notes:
Results based on 100,000 simulations

18





Unrecognized stock-based compensation expense

Unrecognized stock-based compensation expense is presented in the table below (in thousands):
June 30,
 20242023
Unrecognized expense for DLH employees (a)$6,119 $7,358 
Unrecognized expense for non-employee directors180 155 
Total unrecognized expense$6,299 $7,513 

(a) On a weighted average basis, the unrecognized expense as of June 30, 2024 is expected to be recognized within the next 3.17 years.

Stock option activity for the nine months ended June 30, 2024

The aggregate intrinsic value in the table below represents the total pretax intrinsic value (i.e., the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, times the number of shares) that would have been received by the option holders had all option holders exercised their in the money options on those dates. This amount will change based on the fair market value of the Company’s stock. A summary of the Company's stock option awards is as follows:
(in years)
Weighted
WeightedAverage(in thousands)
(in thousands)AverageRemainingAggregate
Number ofExerciseContractualIntrinsic
SharesPriceTermValue
Options outstanding, September 30, 2023
2,278 $8.40 5.80$8,693 
Granted  — — 
Exercised
(535)5.03 — — 
Cancelled(75)11.66 — — 
Options outstanding, June 30, 2024
1,668 $8.94 5.70$7,370 
Vested and exercisable, June 30, 2024
1,408 $8.19 5.30$7,293 
Stock option shares outstanding, vested and unvested balance as follows (in thousands):
June 30,September 30,
20242023
Vested and exercisable1,408 1,608 
Unvested (a)260 670 
Options outstanding1,668 2,278 
(a) Certain awards vest upon satisfaction of certain performance criteria.

19



9. Earnings Per Share
 
Basic earnings per share is calculated by dividing income available to common shareholders by the weighted average number of common shares outstanding and restricted stock grants that vested or are likely to vest during the period. Diluted earnings per share is calculated by dividing income available to common shareholders by the weighted average number of basic common shares outstanding, adjusted to reflect potentially dilutive securities. Diluted earnings per share is calculated using the treasury stock method.

Earnings per share information is presented in the table below (in thousands except for per share amounts):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Numerator:
Net income$1,139 $1,738 $5,102 $4,090 
Denominator:
Denominator for basic net income per share - weighted-average outstanding shares14,232 13,854 14,156 13,638 
Effect of dilutive securities:
Stock options and restricted stock472 685 560 783 
Denominator for diluted net income per share - weighted-average outstanding shares14,704 14,539 14,716 14,421 
Net income per share - basic$0.08 $0.13 $0.36 $0.30 
Net income per share - diluted$0.08 $0.12 $0.35 $0.28 


10. Commitments and Contingencies

Contractual obligations as of June 30, 2024 are as follows (in thousands):
  Payments Due Per Fiscal Year
 (Remaining)
Total20242025202620272028Thereafter
Debt obligations$166,490 $14,490 $9,500 $19,000 $23,750 $99,750 $ 
Facility operating leases19,929 1,108 3,572 3,350 2,751 2,602 6,546 
Total contractual obligations$186,419 $15,598 $13,072 $22,350 $26,501 $102,352 $6,546 

Legal proceedings

As a commercial enterprise and employer, the Company is subject to various claims and legal actions in the ordinary course of business. These matters can include professional liability, employment-relations issues, workers’ compensation, tax, payroll and employee-related matters, other commercial disputes arising in the course of its business, and inquiries and investigations by governmental agencies regarding our employment practices or other matters. The Company is not aware of any pending or threatened litigation that it believes is reasonably likely to have a material adverse effect on its results of operations, financial position or cash flows.


11. Related Party Transactions

The Company has determined that for the nine months ended June 30, 2024 and 2023, there were no significant related party transactions that have occurred which require disclosure through the date that these consolidated financial statements were issued.

20



12. Subsequent Events

Management has evaluated subsequent events through the date that the Company's unaudited consolidated financial statements were issued. Based on this evaluation, the Company has determined that no subsequent events have occurred which require disclosure through the date that these consolidated financial statements were issued.

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
Forward-Looking and Cautionary Statements
 
You should read the following discussion in conjunction with the Consolidated Financial Statements and the notes to those statements included elsewhere in this Quarterly Report on Form 10-Q, as well as our Annual Report on Form 10-K for the year ended September 30, 2023, and in other reports we have subsequently filed with the SEC. This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements contained in this Management’s Discussion and Analysis are forward-looking statements that involve risks and uncertainties. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward-looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this report include, among others, statements regarding benefits of the acquisition, estimates of future revenues, operating income, earnings, earnings per share, backlog, and cash flows. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements made in this report due to a variety of factors, including: the failure to achieve the anticipated benefits of any future acquisition (including anticipated future financial operating performance and results); the diversion of management’s attention from normal daily operations of the business and the challenges of managing larger and more widespread operations; the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our increased debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, as well as interim quarterly filings thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.

Overview and Background

DLH Holdings Corp. ("DLH") delivers improved health and cyber readiness solutions for federal government customers through digital transformation, science research and development, and systems engineering and integration. We bring a unique combination of government sector experience, proven methodology, and unwavering commitment to solve the complex problems faced by civilian and military customers alike, doing so by leveraging multiple capabilities, including cyber technology, artificial intelligence, advanced analytics, cloud-based applications, and telehealth systems.

Competitive Advantages

We believe we are advantageously positioned within our markets through a number of features including, but not limited to:
highly credentialed workforce;
predominantly performing as the prime contractor;
strong past performance record across our government contracts; and
strong bipartisan support for our key contracts.

We have invested in leading credentials and capabilities that we expect will deliver value to our customers. These investments include development of secure Information Technology ("IT") platforms; sophisticated data analytic tools and techniques; and implementation process improvement and quality assurance programs and techniques. We are actively pursuing additional credentials that will support our customers' ever evolving missions.
21




Solutions and Services

We primarily focus on improved deployment of large-scale health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services ("HHS"), the Department of Veterans Affairs ("VA"), Department of Defense ("DoD"), and many of their sub-agencies.

We deliver services primarily through prime contracts awarded by the federal government through competitive bidding processes. We have a diverse mix of contract vehicles with various agencies of the federal government, which supports our overall corporate growth strategy. Our revenue is distributed to time and materials contracts (55.1%), firm fixed price contracts (24.7%), and cost reimbursable contracts (20.1%).

We provide the following services and solutions, which are aligned with the long-term needs of our customers:
Digital Transformation and Cyber Security;
Science Research and Development; and
Systems Engineering and Integration

Digital Transformation and Cyber Security

We provide critical digital transformation and cyber security solutions across the federal civilian and cyber defense communities, leveraging advanced technology to modernize obsolete systems, protect sensitive information, manage large datasets, and enhance operational efficiency. Our suite of tools includes artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation.

IT modernization and cyber security maturity are priority initiatives throughout our customer set. Our customers, including numerous institutes and centers within the National Institutes of Health ("NIH"), the Defense Health Agency ("DHA"), Telemedicine and Advanced Technology Research Center ("TATRC"), and US Navy Naval Information Warfare Center ("NIWC"), rely on our information technology support to enable their vital missions. We work with these customers to reduce risk and build resilience to cyber and physical threats to the federal government’s infrastructure, providing the full spectrum of cyber capabilities, cryptographic and true cyber engineering, Certified Information Security Officer ("CISO") / Information System Security Officer ("ISSO") support, risk management frameworks, Continuity of Operations ("COOP") / Disaster Recovery, and enterprise infrastructure and cloud governance focused on designing and implementing zero trust architecture.

Science Research and Development

We advance scientific knowledge and understanding through our extensive research portfolio and domain expertise. We primarily provide large-scale data analytics, testing and evaluation, clinical trials research services, and epidemiology studies to support multiple operating divisions within HHS, including NIH and the Center for Disease Control and Prevention ("CDC"), as well as the Military Health System.

Our employees support innovative, cutting-edge research on emerging trends, health informatics analyses, and application of best practices including mobile, social, and interactive media. We leverage evidence-based methods and web technology to drive health equity to our most vulnerable populations through public engagement. Projects often involve highly specialized expertise and transformative R&D support services. Our decades of experience designing, conducting, and analyzing studies for our diverse customer base, and our full-service clinical research solutions are designed for each customer’s specific research development program. Our employees provide expert knowledge and experience that supports our customers’ missions.

System Engineering and Integration

Our employees specialize in delivering engineering solutions that support our customers' evolving needs by rapidly deploying resources, solutions, and services. This includes specialized engineering expertise, encompassing areas of pharmaceutical delivery logistics, fire protection engineering, biomedical equipment, and technology engineering on behalf of the VA, NIWC, HHS and other federal customers.

We utilize automation to accelerate infrastructure innovation and help customers define a lifecycle for automation assets, as well as set standards for version control, testing, and release processes that proved a robust foundation for their customers. DLH delivers IT operational resilience and efficiency in parallel with technology innovation integration, via hybrid and multi-cloud solutions, leveraging integrated services, process automation, advanced tool stacks, and mature quality processes. Our
22



employees engineer, implement, and operate solutions that demonstrate measurable results to satisfy our customer’s management requirements, thus helping customers to confidently deploy secure platforms and technologies that reduce operational costs. We have invested in agile software development credentials for our technical staff, and have achieved Capability Maturity Model Integration ("CMMI") level 3. Our enterprise lifecycle logistics support services encompass military systems deployed worldwide, as well as scientific and IT systems and peripherals for Federal civilian agencies.

Major Customers
Our revenues are from agencies of the U.S. Federal government. A major customer is defined as a customer from whom we derive at least 10% of our revenues. The following table summarizes revenue by customer as follows (in thousands and percent):
Nine Months Ended
June 30,
20242023
RevenuePercent of total revenueRevenuePercent of total revenue
Department of Health and Human Services$139,937 46.7 %$115,528 42.1 %
Department of Veterans Affairs105,788 35.3 %104,489 38.1 %
Department of Defense48,458 16.2 %50,802 18.5 %
Other customers with less than 10% share of total revenue5,368 1.8 %3,566 1.3 %
Total revenue$299,551 100.0 %$274,385 100.0 %

We remain dependent upon the continuation of our relationships with our major customers as a significant portion of our revenue is concentrated in each of them. Our results of operations, cash flows and financial condition would be materially adversely affected if we were unable to continue our relationship with any of these customers, if we were to lose any of our material current contracts, or if the amount of services we provide to them is materially reduced.

Major Contracts

We operate primarily through prime contracts awarded by the government through competitive bidding processes. We have a diverse mix of contract vehicles with various agencies of the U.S. government, which supports our overall corporate growth strategy. A major contract is defined as a contract or set of contracts from which we derive at least 10% of our revenues.

The revenue attributable to the VA was derived from 8 separate task orders covering the Company's performance of pharmacy and logistics services in support of the VA's Consolidated Mail Outpatient Pharmacy ("CMOP") program.

Pharmacy services represents approximately $59.5 million and $60.6 million of revenues for the nine months ended June 30, 2024 and 2023, respectively, and operated under task orders effective through July 31, 2024.
Logistics services represents approximately $46.3 million and $43.7 million of revenues for the nine months ended June 30, 2024 and 2023, respectively, and operated under task orders effective through July 31, 2024.

In April 2024, the Company received a new Indefinite-Delivery Indefinite-Quantity ("IDIQ") contract to continue providing prime contractor services at all CMOP locations while the pending procurements are evaluated. The ceiling value of the IDIQ contract is $200.0 million with the initial tasking through July 31, 2024. The customer has indicated their intention to extend the current task orders to October 31, 2024 with the exception of the Chelmsford CMOP location. During the quarter, we were notified that the VA's decision to award the task order for the Chelmsford location to a service-disabled veteran owned small business (“SDVOSB”) that is unaffiliated with DLH has withstood a protest and has been formally awarded. As a result, for the Chelmsford location, the SDVOSB is expected to begin performing services on August 1, 2024. The revenue derived by DLH from its current prime contracts to perform services at this location represents less than 3% of its consolidated revenue for the nine months ended June 30, 2024.

23



During the quarter ended June 30, 2024, the VA issued amendments to the requests for proposals for the seven remaining CMOP locations. The amendments require a current or potentially new bidder to respond to the solicitations' changes with a compliant proposal. Due dates for the proposals have not yet been assigned; once submitted, each procurement will be evaluated separately which may result in differing timelines for releasing an award decision. The solicitations remain set aside for an SDVOSB to perform as the prime contractor. DLH intends to submit revised proposals with our SDVOSB partner as prime contractor. While the acquisition process is being conducted, DLH continues to operate as the prime contractor for all CMOP locations other than the Chelmsford location.

Should the new contracts for performance of these services be awarded to a partner of DLH, the Company expects to continue to perform a significant amount of the contract’s volume of business as a subcontractor. Should the VA conclude that an award to an SDVOSB prime contractor is not in the best interest of the government, they may reissue a solicitation in an unrestricted competition. DLH believes that its service excellence over many years on the program continues to provide the company and its partners with competitive advantages in the ongoing solicitation.

Backlog

At June 30, 2024, our backlog was approximately $670.5 million of which $141.5 million was funded backlog. At September 30, 2023, our backlog was approximately $704.8 million, of which $169.9 million was funded backlog.

We define backlog as our estimate of remaining future revenue from existing signed contracts, assuming the exercise of all options relating to such contracts and including executed task orders issued under Indefinite Quantity/Indefinite Delivery ("IDIQ") contracts or if the contract is a single award IDIQ contract.

We define funded backlog as the portion of backlog for which funding is appropriated and allocated to the contract by the customer and authorized for payment by the customer, once specified work is completed. Funded backlog does not include the full contract value as Congress often appropriates funding for contracts on a yearly or quarterly basis.

Circumstances and events may cause changes in the amount of our backlog and funded backlog, including the execution of new contracts, extension of existing contracts, non-renewal or completion of current contracts, early termination, and adjustments to estimates. Changes in funded backlog may be affected by the funding cycles of the government. While no assurances can be given that existing contracts will result in earned revenue in any future period, or at all, our major customers have historically exercised their contractual renewal options.

Backlog value is quantified from management's judgment and assumptions about the volume of services based on past volume trends and current planning developed with customers.


Forward-Looking Business Trends

Our mission is to expand our position as a trusted provider of technology-enabled healthcare and public health services, medical logistics, and readiness enhancement services to active duty personnel, veterans, and civilian populations and communities. Our primary focus within the defense agency markets includes cyber security, military service members' and veterans' requirements for telehealth services, behavioral healthcare, medication therapy management, process management, clinical systems support, and healthcare delivery. Our primary focus within the civilian agency markets includes digital transformation, IT modernization, healthcare and social programs delivery and readiness. These include compliance monitoring on large scale programs, technology-enabled program management, consulting, and digital communications solutions ensuring that education, health, and social standards are being achieved within underserved and at-risk populations. We believe these business development priorities will position the Company to expand within top national priority programs and funded areas.

Potential impact of federal contractual set-aside laws and regulations:

The Federal government has an overall goal of 23% of prime contracts flowing through small businesses. As previously reported, various agencies within the federal government have policies that support small business goals, including the adoption of the “Rule of Two” by the VA, which provides that the agency shall award contracts by restricting competition for the contract to service-disabled or other veteran-owned businesses. To restrict competition pursuant to this rule, the contracting officer must reasonably expect that at least two of these businesses, which are capable of delivering the services, will submit offers and that the award can be made at a fair and reasonable price that offers best value to the U.S. When two qualifying small businesses cannot be identified, the VA may proceed to award contracts following a full and open bid process.
24




The Company believes that its past performance in this market and track record of success provide a competitive advantage. However, the effect of set-aside provisions may limit our ability to compete for prime contractor positions on programs that we recompete or that we have targeted for growth. In these cases, the Company may elect to join a team with an eligible contractor as prime for specific pursuits that align with our core markets and corporate growth strategy.


Results of Operations

The following table summarizes results of operations for the three months ended June 30, 2024 and 2023 (in thousands except for per share amounts, and percentage of revenue):
Three Months Ended
June 30
Consolidated Statements of  Operations:20242023Change
Revenue$100,694 100.0 %$102,241 100.0 %$(1,547)
Cost of operations:
Contract costs81,646 81.1 %80,919 79.1 %727 
General and administrative costs9,013 9.0 %9,935 9.7 %(922)
Depreciation and amortization4,272 4.2 %4,280 4.2 %(8)
Total operating costs94,931 94.3 %95,134 93.0 %(203)
Income from operations5,763 5.7 %7,107 7.0 %(1,344)
Interest expense4,143 4.1 %4,917 4.9 %(774)
Income before provision for income tax1,620 1.6 %2,190 2.1 %(570)
Provision for income tax expense481 0.5 %452 0.4 %29 
Net income$1,139 1.1 %$1,738 1.7 %$(599)
Net income per share - basic$0.08 $0.13 $(0.05)
Net income per share - diluted$0.08 $0.12 $(0.04)

Revenue
 
Revenue decreased $1.5 million for the three months ended June 30, 2024 over 2023, reflecting growth across the Company's programs, particularly in public health and IT services, offset by contracts converting to small business set-aside companies.

Cost of Operations

Contract costs primarily include the costs associated with providing services to our customers. These costs are generally comprised of direct labor and associated fringe benefit costs, subcontract cost, other direct costs, and the related management and infrastructure costs. Contract costs increased $0.7 million for the three months ended June 30, 2024 over 2023; the increase was primarily due to an increase in non-labor costs.

General and administrative costs are for those employees not directly providing services to our customers, to include but not limited to executive management, business development, accounting, and human resources. These costs decreased $0.9 million for the three months ended June 30, 2024 as compared to 2023. As a percentage of revenue general and administrative costs decreased to 9.0% from 9.7%, the decrease was primarily due to a decrease in episodic legal costs.

For the three months ended June 30, 2024, depreciation and amortization expense were approximately $0.2 million and $4.1 million, respectively, as compared to approximately $0.2 million and $4.1 million for the three months ended June 30, 2023, respectively.

25



Interest Expense, net
 
Interest expense, net, includes interest expense on the Company's term loan and amortization of deferred financing costs on debt obligations. Interest expense decreased $0.8 million for the three months ended June 30, 2024 over 2023, primarily due to the prepayment of debt resulting in reduced interest payments.

Provision for Income Tax Expense

Provision for income tax expense increased $29.0 thousand for the three months ended June 30, 2024 over 2023. The effective tax rate for the three months ended June 30, 2024 and 2023 was 29.7% and 20.6%, respectively. The increase in the effective tax rate in the current fiscal quarter is primarily due to the beneficial impact of stock-based compensation expense as options were exercised in the same quarter in the prior fiscal year.


The following table summarizes results of operations for the nine months ended June 30, 2024 and 2023 (in thousands except for per share amounts, and percentage of revenue):
Nine Months Ended
June 30
Consolidated Statements of  Operations:20242023Change
Revenue$299,551 100.0 %$274,385 100.0 %$25,166 
Cost of operations:
Contract costs239,839 80.1 %216,779 79.0 %23,060 
General and administrative costs28,420 9.5 %27,670 10.1 %750 
Corporate development costs— — %1,735 0.6 %(1,735)
Depreciation and amortization12,769 4.3 %11,281 4.1 %1,488 
Total operating costs281,028 93.8 %257,465 93.8 %23,563 
Income from operations18,523 6.2 %16,920 6.2 %1,603 
Interest expense12,991 4.3 %11,512 4.2 %1,479 
Income before provision for income tax
5,532 1.8 %5,408 2.0 %124 
Provision for income tax expense430 0.1 %1,318 0.5 %(888)
Net income$5,102 1.7 %$4,090 1.5 %$1,012 
Net income per share - basic$0.36 $0.30 $0.06 
Net income per share - diluted$0.35 $0.28 $0.07 

Revenue
 
Revenue increased $25.2 million for the nine months ended June 30, 2024 over 2023, principally due to the December 2022 acquisition.

Cost of Operations

Contract costs primarily include the costs associated with providing services to our customers. These costs are generally comprised of direct labor and associated fringe benefit costs, subcontract cost, other direct costs, and the related management and infrastructure costs. Contract costs increased $23.1 million for the nine months ended June 30, 2024 over 2023. The increase in costs is primarily due to increased revenue.

General and administrative costs are for those employees not directly providing services to our customers, to include but not limited to executive management, business development, accounting, and human resources. These costs increased $0.8 million for the nine months ended June 30, 2024 over 2023. As a percentage of revenue, general and administrative costs decreased to 9.5% from 10.1%. The decrease was primarily due to increased operating leverage.

26



For the nine months ended June 30, 2024, depreciation and amortization expense were approximately $0.4 million and $12.3 million, respectively, as compared to approximately $0.6 million and $10.7 million for the nine months ended June 30, 2023, respectively.

Interest Expense, net

Interest expense, net, includes interest expense on the Company's term loan and amortization of deferred financing costs on debt obligations. Interest expense increased $1.5 million for nine months ended June 30, 2024 over 2023, primarily due to the borrowing required to finance the December 2022 acquisition.

Provision for Income Tax Expense

Provision for income tax expense decreased $0.9 million for the nine months ended June 30, 2024 over 2023. The effective tax rate for the nine months ended June 30, 2024 and 2023 was 7.8% and 24.4%, respectively. The decrease in the effective tax rate in the current fiscal year is primarily due to the beneficial impact of stock based compensation expense as options are exercised.


Non-GAAP Financial Measures

The Company uses EBITDA as a supplemental non-GAAP measure of our performance. DLH defines EBITDA as net income excluding (i) interest expense, (ii) income tax expense and benefit, and (iii) depreciation and amortization.

On a non-GAAP basis, Earnings Before Interest, Tax, Depreciation, and Amortization ("EBITDA") for the nine months ended June 30, 2024 and 2023 was approximately $31.3 million and $28.2 million, respectively. The increase was principally due to the contribution of the December 2022 acquisition.

This non-GAAP measure of our performance is used by management to conduct and evaluate its business during its regular review of operating results for the periods presented. Management and our Board utilize this non-GAAP measure to make decisions about the use of our resources, analyze performance between periods, develop internal projections and measure management's performance. We believe that this non-GAAP measure is useful to investors in evaluating our ongoing operating and financial results and understanding how such results compare with our historical performance. By providing this non-GAAP measure as a supplement to GAAP information, we believe this enhances investors understanding of our business and results of operations. EBITDA is not a recognized measurement under accounting principles generally accepted in the United States, or GAAP, and when analyzing our performance investors should (i) evaluate adjustments in our reconciliation to the nearest GAAP financial measures and (ii) use non-GAAP measures in addition to, and not as an alternative to, measures of our operating results as defined under GAAP.

Reconciliation of GAAP net income to EBITDA, a non-GAAP measure (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
20242023Change20242023Change
Net income$1,139 $1,738 $(599)$5,102 $4,090 $1,012 
(i) Interest expense, net4,143 4,917 (774)12,991 11,512 1,479 
(ii) Provision for income tax expense481 452 29 430 1,318 (888)
(iii) Depreciation and amortization4,272 4,280 (8)12,769 11,281 1,488 
EBITDA$10,035 $11,387 $(1,352)$31,292 $28,201 $3,091 

27



Liquidity and capital management

Cash is approximately $0.4 million and $0.2 million for the period ended June 30, 2024 and September 30, 2023, respectively.

Credit facility is total approximately $24.0 million and $32.0 million for the period ended June 30, 2024 and September 30, 2023, respectively. The decrease is primarily due to increased collections which reduce accounts receivable, thereby reducing the collateral available for the revolving credit facility.


A summary of the change in cash is presented as follows (in thousands):
Six Months Ended
20242023Change
Net cash provided by operating activities
$14,931 $14,997 $(66)
Net cash used in investing activities(627)(181,291)180,664 
Net cash (used in) provided by financing activities
(14,096)166,596 (180,692)
Net change in cash$208 $302 $(94)

Cash flows provided by operating activities totaled approximately $14.9 million and $15.0 million for the nine months ended June 30, 2024 and 2023, respectively.

Cash used in investing activities totaled $0.6 million and $181.3 million for the nine months ended June 30, 2024 and 2023, respectively. The cash utilized in the prior fiscal year period was predominantly due to the December 2022 acquisition.
 
Cash used in and provided by financing activities during the nine months ended June 30, 2024 and 2023 were approximately $14.1 million and $166.6 million, respectively. The cash used by financing activities was principally due to retiring of outstanding term debt in the nine months ended June 30, 2024. The cash provided financed the December 2022 acquisition in the nine months ended June 30, 2023.

Sources of cash

As of June 30, 2024, our immediate sources of liquidity include cash of approximately $0.4 million, accounts receivable, and access to our secured revolving line of credit facility. This credit facility provides us with access of up to $70.0 million, subject to certain conditions including eligible accounts receivable. As of June 30, 2024, we had unused borrowing capacity of $24.0 million, which is net of outstanding letters of credit. The Company's present operating liabilities are largely predictable and consist of vendor and payroll related obligations. We believe that our current investment and financing obligations are adequately covered by cash generated from profitable operations and that planned operating cash flow should be sufficient to support our operations for twelve months from the date of issuance of these consolidated financial statements.

Credit Facilities

A summary of our credit facilities for the period ended June 30, 2024 is as follows (in thousands):
ArrangementLoan BalanceInterest*Maturity Date
Secured term loan (a) due December 8, 2027$152,000 
SOFR1 + 4.1%
December 8, 2027
Secured revolving line of credit (b) due December 8, 2027$14,490 
SOFR1 + 4.1%
December 8, 2027
1Secured Overnight Financing Rate ("SOFR") as of June 30, 2024 was 5.3%.
On January 31, 2023, we executed a floating-to-fixed interest rate swap with FNB which has a notional amount of $80.0 million at June 30, 2024, a fixed interest rate is 4.10% and a maturity date of January 31, 2026. As a result of entering these agreements, for the nine months ended June 30, 2024, interest expense has been decreased by approximately $1.0 million.

(a) Represents the principal amounts payable on our term loan, which is secured by liens on substantially all of the assets of the Company. The principal of the term loan is payable in quarterly installments with the remaining balance due on December 8, 2027

28



(b) The secured revolving line of credit has a ceiling of up to $70.0 million and a maturity date of December 8, 2027. The Company has accessed funds from the revolving credit facility during the quarter and has a balance outstanding at June 30, 2024 of $14.5 million
The secured term loan and secured revolving line of credit are secured by liens on substantially all of the assets of the Company. The provisions of our credit facilities are fully described in Note 7. Credit Facilities to the consolidated financial statements.

Contractual Obligations
Contractual obligations as of June 30, 2024 are as follows (in thousands):
Payments Due by Period
Next 122-34-5More than 5
TotalMonthsYearsYearsYears
Debt obligations$166,490 $19,240 $41,563 $105,688 $— 
Facility operating leases19,930 2,889 5,141 5,353 6,546 
Total contractual obligations$186,420 $22,129 $46,704 $111,041 $6,546 
Critical Accounting Policies and Estimates
 
Our critical accounting policies and estimates are disclosed in the Critical Accounting Policies and Estimates section in Part II, “Item 7. Management's Discussion of our Annual Report on Form 10-K for the year ended September 30, 2023. There have been no significant changes to the Company’s critical accounting policies as disclosed in our Annual Report on Form 10-K for the year ended September 30, 2023. For a detailed discussion on the application of accounting policies, refer to Note 2. Significant Accounting Policies.

ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Except as described elsewhere in this report, the Company has not engaged in trading practices in securities or other financial instruments and therefore does not have any material exposure to interest rate risk, foreign currency exchange rate risk, commodity price risk or other similar risks, which might otherwise result from such practices. The Company has limited foreign operations and therefore is not materially subject to fluctuations in foreign exchange rates, commodity prices or other market rates or prices from market sensitive instruments. We have executed a set of floating-to-fixed interest rate swaps with a total notional amount of $80 million at June 30, 2024. The remaining balance of our debt is subject to floating interest rates.

We have determined that a 1.0% increase to SOFR would impact our interest expense by approximately $0.9 million per year. As of June 30, 2024, the interest rate on the floating interest rate debt was 9.4%.

ITEM 4: CONTROLS AND PROCEDURES
 
Evaluation of Disclosure Controls and Procedures
 
Our CEO and President and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based on the evaluation of these controls and procedures, our disclosure controls and procedures were effective at the reasonable assurance level to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 (i) is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) that such information is accumulated and communicated to our management, including our CEO and President and Chief Financial Officer, to allow timely decisions regarding required disclosure.
 
Our management, including our CEO and President and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. Our
29



management, however, believes our disclosure controls and procedures are in fact effective to provide reasonable assurance that the objectives of the control system are met.
 
Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934) identified in connection with the evaluation of our internal controls that occurred during the fiscal quarter ended June 30, 2024, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II OTHER INFORMATION 

ITEM 1: LEGAL PROCEEDINGS

As a commercial enterprise and employer, the Company is subject to various claims and legal actions in the ordinary course of business. These matters can include professional liability, workers’ compensation, tax, payroll and employee-related matters, other commercial disputes arising in the course of its business, and inquiries and investigations by governmental agencies regarding our employment practices or other matters. The Company is not aware of any pending or threatened litigation that it believes is reasonably likely to have a material adverse effect on its results of operations, financial position or cash flows.
 
ITEM 1A: RISK FACTORS
 
Our operating results and financial condition have varied in the past and may in the future vary significantly depending on a number of factors. In addition to the other information set forth in this report, you should carefully consider the factors discussed in the “Risk Factors” section in our Annual Report on Form 10-K for the year ended September 30, 2023 and in our other reports filed with the SEC concerning the risks associated with our business, financial condition and results of operations. These factors, among others, could materially and adversely affect our business, results of operations, financial condition or liquidity and cause our actual results to differ materially from those contained in statements made in this report and presented elsewhere by management from time to time. The risks we have identified in our reports are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently believe are immaterial may also materially adversely affect our business, results of operations, financial condition or liquidity. See Item 1A, Risk Factors, in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023. We believe that there have been no material changes from the risk factors described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023.

ITEM 2: UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
During the period covered by this report, the Company did not issue any securities that were not registered under the Securities Act of 1933, as amended, except as has been reported in previous filings with the SEC or as set forth elsewhere herein. 


ITEM 3: DEFAULTS UPON SENIOR SECURITIES
 
None.

ITEM 4: MINE SAFETY DISCLOSURES
 
Not applicable.

ITEM 5: OTHER INFORMATION
 
(a) None

(b) None

(c) During the three months ended June 30, 2024, no director or office of the Company adopted or terminated a "rule 10b5-1 trading arrangement" or "non-rule 10b5-1 trading arrangement," as each term is defined in Item 408 (a) of Regulation S-K.
30



ITEM 6: EXHIBITS
 
Exhibits to this report which have previously been filed with the Commission are incorporated by reference to the document referenced in the following table. The exhibits designated with a number sign (#) indicate a management contract or compensation plan or arrangement.
Exhibit Incorporated by Reference Filed
NumberExhibit DescriptionForm Dated Exhibit Herewith
31.1      X
31.2      X
32.0      X
101.0
The following financial information from the DLH Holdings Corp. Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language) and filed electronically herewith: (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Operations; (iii) the Consolidated Statements of Cash Flows; and, (iv) the Notes to the Consolidated Financial Statements.
      X
104.0Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)


31



SIGNATURE
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized
  DLH HOLDINGS CORP.
    
  By:/s/ Kathryn M. JohnBull
   Kathryn M. JohnBull
   Chief Financial Officer
   (On behalf of the Registrant and as
Principal Financial and Accounting Officer)
   
Dated: July 31, 2024
   
32

{N0401184 } EXHIBIT 31.1 Certification I, Zachary C. Parker, certify that: 1. I have reviewed this quarterly report on Form 10-Q of DLH Holdings Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. Date: July 31, 2024 /s/ Zachary C. Parker Zachary C. Parker Chief Executive Officer (Principal Executive Officer)


 
{N0401184 } EXHIBIT 31.2 Certification I, Kathryn M. JohnBull, certify that: 1. I have reviewed this quarterly report on Form 10-Q of DLH Holdings Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. Date: July 31, 2024 /s/ Kathryn M. JohnBull Kathryn M. JohnBull Chief Financial Officer (Principal Accounting Officer)


 
{N0401184 } EXHIBIT 32 Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Quarterly Report of DLH Holdings Corp. (the “Company”) on Form 10-Q for the period ended June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, being, Zachary C. Parker, Chief Executive Officer, and Kathryn M. JohnBull, Chief Financial Officer and Principal Accounting Officer, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. Dated: July 31, 2024 /s/ Zachary C. Parker _____ /s/ Kathryn M. JohnBull ____ Zachary C. Parker Kathryn M. JohnBull Chief Executive Officer (Principal Executive Officer) Chief Financial Officer (Principal Accounting Officer) A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.


 
v3.24.2
Cover - $ / shares
9 Months Ended
Jun. 30, 2024
Jul. 30, 2024
Sep. 30, 2023
Cover [Abstract]      
Document Type 10-Q    
Document Quarterly Report true    
Document Period End Date Jun. 30, 2024    
Document Transition Report false    
Entity File Number 0-18492    
Entity Registrant Name DLH HOLDINGS CORP.    
Entity Incorporation, State or Country Code NJ    
Entity Tax Identification Number 22-1899798    
Entity Address, Address Line One 3565 Piedmont Road,    
Entity Address, Address Line Two Building 3,    
Entity Address, Address Line Three Suite 700    
Entity Address, City or Town Atlanta,    
Entity Address, State or Province GA    
Entity Address, Postal Zip Code 30305    
City Area Code 770    
Local Phone Number 554-3545    
Title of 12(b) Security Common Stock    
Trading Symbol DLHC    
Security Exchange Name NASDAQ    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding   14,182,891  
Common stock, par value (in dollars per share) $ 0.001 $ 0.001 $ 0.001
Entity Central Index Key 0000785557    
Amendment Flag false    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus Q3    
Current Fiscal Year End Date --09-30    
v3.24.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenue $ 100,694 $ 102,241 $ 299,551 $ 274,385
Contract costs 81,646 80,919 239,839 216,779
General and administrative costs 9,013 9,935 28,420 27,670
Corporate development costs 0 0 0 1,735
Depreciation and amortization 4,272 4,280 12,769 11,281
Total operating costs 94,931 95,134 281,028 257,465
Income from operations 5,763 7,107 18,523 16,920
Interest expenses 4,143 4,917 12,991 11,512
Income before provision for income tax 1,620 2,190 5,532 5,408
Provision for income tax expense 481 452 430 1,318
Net income $ 1,139 $ 1,738 $ 5,102 $ 4,090
Net income per share - basic (in dollars per share) $ 0.08 $ 0.13 $ 0.36 $ 0.30
Net income per share - diluted (in dollars per share) $ 0.08 $ 0.12 $ 0.35 $ 0.28
Weighted average common stock outstanding        
Basic (in shares) 14,232 13,854 14,156 13,638
Diluted (in shares) 14,704 14,539 14,716 14,421
v3.24.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Current assets:    
Cash $ 423 $ 215
Accounts receivable 58,341 59,119
Other current assets 2,742 3,067
Total current assets 61,506 62,401
Goodwill 138,161 138,161
Intangible assets, net 112,435 124,777
Operating lease right-of-use assets 7,498 9,656
Deferred taxes, net 3,381 3,070
Equipment and improvements, net 1,790 1,590
Other long-term assets 186 186
Total assets 324,957 339,841
Current liabilities:    
Accounts payable and accrued liabilities 23,189 29,704
Debt obligations - current, net of deferred financing costs 17,646 17,188
Accrued payroll 14,232 13,794
Operating lease liabilities - current 2,889 3,463
Other current liabilities 482 638
Total current liabilities 58,438 64,787
Long-term liabilities:    
Debt obligations - long-term, net of deferred financing costs 143,258 155,147
Operating lease liabilities - long-term 13,521 15,908
Other long-term liabilities 1,135 1,560
Total long-term liabilities 157,914 172,615
Total liabilities 216,352 237,402
Shareholders' equity:    
Common stock, $0.001 par value; 40,000 shares authorized; 14,183 and 13,950 shares issued and outstanding at June 30, 2024 and September 30, 2023, respectively 14 14
Additional paid-in capital 101,038 99,974
Retained earnings 7,553 2,451
Total shareholders’ equity 108,605 102,439
Total liabilities and shareholders' equity $ 324,957 $ 339,841
v3.24.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
shares in Thousands
Jun. 30, 2024
Sep. 30, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, authorized (in shares) 40,000 40,000
Common stock, issued (in shares) 14,183 13,950
Common stock, outstanding (in shares) 14,183 13,950
v3.24.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities    
Net income $ 5,102 $ 4,090
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 12,769 11,281
Amortization of deferred financing costs charged to interest expense 1,437 1,540
Stock-based compensation expense 2,290 2,020
Deferred taxes, net (311) 0
Changes in operating assets and liabilities:    
Accounts receivable 778 (1,918)
Other assets 2,484 130
Accounts payable and accrued liabilities (6,515) (4,221)
Accrued payroll 437 274
Other liabilities (3,540) 1,801
Net cash provided by operating activities 14,931 14,997
Investing activities    
Business acquisition, net of cash acquired 0 (180,711)
Purchase of equipment and improvements (627) (580)
Net cash (used in) investing activities (627) (181,291)
Financing activities    
Proceeds from revolving line of credit 257,067 144,697
Repayment of revolving line of credit (252,123) (128,204)
Proceeds from debt obligations 0 168,000
Repayments of debt obligations (17,813) (10,688)
Payments of deferred financing costs 0 (7,666)
Proceeds from issuance of common stock upon exercise of options and warrants 261 1,107
Payment of tax obligations resulting from net exercise of stock options (1,488) (650)
Net cash (used in) provided by financing activities (14,096) 166,596
Net change in cash 208 302
Cash - beginning of period 215 228
Cash - end of period 423 530
Supplemental disclosure of cash flow information    
Cash paid during the period for interest 11,656 10,006
Cash paid during the period for income taxes 2,280 4,055
Common stock surrendered for the exercise of stock options $ 2,432 $ 238
v3.24.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Beginning Balance (in shares) at Sep. 30, 2022   13,047    
Beginning balance at Sep. 30, 2022 $ 92,060 $ 13 $ 91,057 $ 990
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance and fair value adjustment of common stock in business combination (in shares)   527    
Issuance and fair value adjustment of common stock in business combination 6,539 $ 1 6,538  
Expense related to director restricted stock units 539   539  
Expense related to employee stock-based compensation 1,481   1,481  
Exercise of stock options (in shares)   393    
Exercise of stock options 1,107   1,107  
Common stock surrendered for the exercise of stock options (in shares)   (67)    
Common stock surrendered for the exercise of stock options (650)   (650)  
Net income 4,090     4,090
Ending Balance (in shares) at Jun. 30, 2023   13,900    
Ending balance at Jun. 30, 2023 105,166 $ 14 100,072 5,080
Beginning Balance (in shares) at Mar. 31, 2023   13,793    
Beginning balance at Mar. 31, 2023 101,940 $ 14 98,584 3,342
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Expense related to director restricted stock units 179   179  
Expense related to employee stock-based compensation 489   489  
Exercise of stock options (in shares)   107    
Exercise of stock options 820   820  
Net income 1,738     1,738
Ending Balance (in shares) at Jun. 30, 2023   13,900    
Ending balance at Jun. 30, 2023 $ 105,166 $ 14 100,072 5,080
Beginning Balance (in shares) at Sep. 30, 2023 13,950 13,950    
Beginning balance at Sep. 30, 2023 $ 102,439 $ 14 99,974 2,451
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Expense related to director restricted stock units 439   439  
Expense related to employee stock-based compensation $ 1,851   1,851  
Exercise of stock options (in shares) 535 535    
Exercise of stock options $ 261   261  
Common stock surrendered for the exercise of stock options (in shares)   (302)    
Common stock surrendered for the exercise of stock options (1,487)   (1,487)  
Net income $ 5,102     5,102
Ending Balance (in shares) at Jun. 30, 2024 14,183 14,183    
Ending balance at Jun. 30, 2024 $ 108,605 $ 14 101,038 7,553
Beginning Balance (in shares) at Mar. 31, 2024   14,230    
Beginning balance at Mar. 31, 2024 106,750 $ 14 100,322 6,414
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Expense related to director restricted stock units 180   180  
Expense related to employee stock-based compensation 537   537  
Common stock surrendered for the exercise of stock options (in shares)   (47)    
Common stock surrendered for the exercise of stock options (1)   (1)  
Net income $ 1,139     1,139
Ending Balance (in shares) at Jun. 30, 2024 14,183 14,183    
Ending balance at Jun. 30, 2024 $ 108,605 $ 14 $ 101,038 $ 7,553
v3.24.2
Basis of Presentation and Principles of Consolidation
9 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Principles of Consolidation Basis of Presentation and Principles of Consolidation
The accompanying consolidated financial statements include the accounts of DLH Holdings Corp. and its wholly-owned subsidiaries (together with its subsidiaries, "DLH" or the "Company" and also referred to as "we," "us" and "our"). All significant intercompany balances and transactions have been eliminated in consolidation. The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, these statements do not include all of the information and footnotes required by GAAP for complete financial statements.

Operating results for the nine months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the year ending September 30, 2024 or any future period. Amounts as of June 30, 2024 and for the three and nine months ended June 30, 2024 are unaudited. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2023 filed with the Securities and Exchange Commission on December 6, 2023.
v3.24.2
Significant Accounting Policies
9 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Significant Accounting Policies Significant Accounting Policies
Use of Estimates
 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The most significant of these estimates and assumptions relate to estimating costs including overhead and its allocation, valuing and determining the amortization periods for long-lived intangible assets, interest rate swaps, stock-based compensation, and right-of-use assets and lease liabilities. We evaluate these estimates and judgments on an ongoing basis and base our estimates on historical experience, current and expected future outcomes, third-party evaluations, and various other assumptions that we believe are reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities as well as identifying and assessing the accounting treatment with respect to commitments and contingencies. We revise material accounting estimates if changes occur, such as more experience is acquired, additional information is obtained, or there is new information on which an estimate was or can be based. Actual results could differ from those estimates.

Revenue

The Company's revenues from contracts with customers are derived from offerings that include technology-enabled business process outsourcing, program management solutions, and public health research and analytics, substantially within the U.S. government and its agencies. The Company has various types of contracts including time-and-materials contracts, cost-reimbursable contracts, and firm-fixed-price contracts.

We consider a contract with a customer to exist when there is a commitment by both parties (customer and Company), payment terms are determinable, there is commercial substance, and collectability is probably in accordance with Accounting Standards Codification ("ASC") No. 606, "Revenue from Contracts with Customers" ("Topic 606").

We recognize revenue over time when there is a continuous transfer of control to our customer as performance obligations are satisfied. For our U.S. government contracts, this continuous transfer of control to the customer is transferred over time and revenue is recognized based on the extent of progress toward completion of the performance obligation. We consider control to transfer when we have a right to payment. In some instances, the Company commences providing services prior to formal approval to begin work from the customer. The Company considers these factors, the risks associated with commencing work, and legal enforceability in determining whether a contract exists under Topic 606.

Contract modification can occur throughout the life of the contract and can affect the transaction price, extend the period of performance, adjust funding, or create new performance obligations. We review each modification to assess the impact of these contract changes to determine if it should be treated as part of the original performance obligation or as a separate contract.
Contract modifications impact performance obligations when the modification either creates new or changes the existing enforceable rights and obligations. The effect of a contract modification on the transaction price and our measure of progress for the performance obligation to which it relates is recognized as an adjustment to revenue and profit cumulatively. Furthermore, a significant change in one or more estimates could affect the profitability of our contracts. We recognize adjustments in estimated profit on contracts in the period identified.

For service contracts, we satisfy our performance obligations as services are rendered. We use cost-based input and time-based output methods to measure progress based on the contract type.

Time and material - We bill the customer per labor hour and per material, and revenue is recognized in the amount invoiced as the amount corresponds directly to the value of our performance to date. Revenue is recognized to the extent of billable rates times hours delivered plus materials and other reimbursable costs incurred.
Cost reimbursable - We record reimbursable costs as incurred, including an estimated share of the contractual fee earned.
Firm fixed price - We recognize revenue over time using a straight-line measure of progress.

Contract costs generally include direct costs such as labor, materials, subcontract costs, and indirect costs identifiable with or allocable to a specific contract. Costs are expensed as incurred and include an estimate of the contractual fees earned. Contract costs incurred for U.S. government contracts, including indirect costs, are subject to audit and adjustment by various government audit agencies. Historically, our adjustments have not been material.

Contract assets - Amounts are invoiced as work progresses in accordance with agreed-upon contractual terms. In part, revenue recognition occurs before we have the right to bill, resulting in contract assets. These contract assets are reported within accounts receivable on our consolidated balance sheets and are invoiced in accordance with payment terms defined in each contract. Period end balances will vary from period to period due to agreed-upon contractual terms.

Fair Value of Financial Instruments
 
The carrying amounts of the Company's cash, accounts receivable, contract assets, accrued expenses, and accounts payable approximate fair value due to the short-term nature of these instruments. The fair values of the Company's debt instruments approximate fair value because the underlying interest rates approximate market rates that the Company could obtain for similar instruments at the balance sheet dates.

Long-Lived Assets

Our long-lived assets include equipment and improvements, intangible assets, right-of-use assets, and goodwill. The Company continues to review long-lived assets for possible impairment or loss of value at least annually, or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit's carrying amount is greater than its fair value.

Equipment and improvements are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful asset lives (3 to 7 years) and the shorter of the initial lease term or estimated useful life for leasehold improvements. Maintenance and repair costs are expensed as incurred. Intangible assets (other than goodwill) are originally recorded at fair value and are amortized on a straight-line basis over their estimated useful lives of 10 years.

Right-of-use assets are measured at the present value of future minimum lease payments, including all probable renewals, plus lease payments made to the lessor before or at lease commencement and indirect costs paid, less incentives received. Our right-of-use assets include long-term leases for facilities and equipment and are amortized over their respective lease terms.
Lease Liabilities

The Company has leases for facilities and office equipment. Our lease liabilities are recognized as the present value of the future minimum lease payments over the lease term. Our lease payments consist of fixed and in-substance fixed amounts attributable to the use of the underlying asset over the lease term. Variable lease payments that do not depend on an index rate or are not in-substance fixed payments are excluded in the measurement of right-of-use assets and lease liabilities and are expensed in the period incurred. The incremental borrowing rate on our secured term loan is used in determining the present value of future minimum lease payments. Some of our lease agreements include options to extend the lease term or terminate the lease. These options are accounted for in our right-of-use assets and lease liabilities when it is reasonably certain that the Company will extend the lease term or terminate the lease. The Company does not have any finance leases.

Goodwill

The Company reviews goodwill for impairment on an annual basis and on a quarterly basis the Company assesses the impact of any macroeconomic changes that may impact the business conditions to determine if these changes have any adverse impact to goodwill. Notwithstanding this evaluation, factors including non-renewal of a major contract or other substantial changes in business conditions could have a material adverse effect on the valuation of goodwill in future periods and the resulting charge could be material to future periods’ results of operations. The Company determined that no change in business conditions occurred which would have a material adverse effect on the valuation of goodwill.

Income Tax

The Company accounts for income taxes in accordance with the asset and liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reflected on the consolidated balance sheets when it is determined that it is more likely than not that the asset will be realized. This guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax asset will not be realized. We account for uncertain tax positions by recognizing the financial statement effects of a tax position only when, based upon the technical merits, it is more likely than not that the position will be sustained upon examination. We had no uncertain tax positions at either June 30, 2024 or September 30, 2023. We report interest and penalties as a component of provision for income taxes. During the three and nine months ended June 30, 2024 and 2023, we recognized no interest and no penalties related to income taxes.

Stock-Based Compensation

The Company uses the fair value-based method for stock-based compensation. Options issued are designated as either an incentive stock option or a non-statutory stock option. No option may be granted with a term of more than 10 years from the date of grant. Option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued common shares. All awards to employees and non-employees are recorded at fair value on the date of the grant and expensed over the period of vesting. The Company uses a Monte Carlo method to estimate the fair value of each stock option at the date of grant. Any consideration paid by the option holders to purchase shares is credited to common stock.

Stock-based compensation expense for the portion of equity awards for which the requisite service has not been rendered is recognized as the requisite service is rendered. The stock-based compensation expense for that portion of awards has been based on the grant-date fair value of those awards as calculated for recognition purposes under applicable guidance. For options that vest based on the Company’s common stock achieving and maintaining defined market prices, the Company values the awards with a Monte Carlo method that utilizes various probability factors and other criterion in establishing fair value of the grant. The related compensation expense is recognized over the service period.
Cash

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. We maintain cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation up to $250,000. Deposits held with financial institutions may exceed the $250,000 limit.

Accounts Receivable

Receivables include amounts billed and currently due from customers where the right to consideration is unconditional and amounts unbilled. Both billed and unbilled amounts are non-interest bearing, unsecured, and recognized at an estimated realizable value that includes costs and fees, and are generally expected to be billed and received within a single year. We evaluate our receivables for expected credit losses on a quarterly basis and determine whether an allowance for expected credit losses is appropriate based on specific collection issues.

Earnings Per Share

Basic earnings per share is calculated by dividing income available to common shareholders by the weighted average number of common stock outstanding and restricted stock grants that vested or are likely to vest during the period. Diluted earnings per share is calculated by dividing income available to common shareholders by the weighted average number of basic common shares outstanding, adjusted to reflect potentially dilutive securities. Diluted earnings per share is calculated using the treasury stock method.

Treasury Stock

The Company periodically purchases its own common stock that is traded on public markets as part of announced stock repurchase programs. The repurchased common stock is classified as treasury stock on the consolidated balance sheets and held at cost. As of June 30, 2024 and September 30, 2023, the Company did not hold any treasury stock.

Preferred Stock

Our certificate of incorporation authorizes the issuance of "blank check" preferred stock with designations, rights and preferences as may be determined from time to time by our board of directors up to an aggregate of 5,000,000 shares of preferred stock. As of June 30, 2024 and September 30, 2023, the Company has not issued any preferred stock.

Interest Rate Swap

The Company uses derivative financial instruments to manage interest rate risk associated with its variable debt. The Company's objective in using these interest rate derivatives is to manage its exposure to interest rate movements and reduce volatility of interest expense. The gains and losses due to changes in the fair value of the interest rate swap agreements completely offset changes in the fair value of the hedged portion of the underlying debt. Offsetting changes in fair value of both the interest rate swaps and the hedged portion of the underlying debt are recognized in interest expense in the consolidated statements of operations. The Company does not hold or issue any derivative instruments for trading or speculative purposes.

Risks and Uncertainties

Management evaluates the impact of global markets and economic factors on our industry and the potential for adverse effects on the Company's consolidated financial position and its operations. As of June 30, 2024 and September 30, 2023 there was no indication of any global or economic impacts to our industry.
v3.24.2
New Accounting Pronouncements
9 Months Ended
Jun. 30, 2024
Accounting Changes and Error Corrections [Abstract]  
New Accounting Pronouncements New Accounting Pronouncements
In November 2023, Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" which provides guidance intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses, and each reported measure of segment profit or loss. The ASU requires that a public entity that has a single reportable segment provide all the disclosures required by the amendments in this ASU and all existing segment disclosures in Topic 280. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2023 and interim
periods beginning after December 15, 2024. We are currently evaluating the impacts of the single reportable segment disclosures.

In December 2023, FASB issued ASU 2023-09 "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" which provides guidance on the requirements such as the requirement that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. DLH is a public company that reports income tax disclosures and therefore this ASU applies to the Company. ASU 2023-09 is effective for public business entities for fiscal years beginning after Dec. 15, 2024. We are currently evaluating the impacts of the improvements to income tax disclosure.

In March 2024, FASB issued ASU No. 2024-01, "Scope Application of Profits Interest and Similar Awards". The ASU clarifies how an entity determines whether a profits interest or similar award is (1) within the scope of ASC 718 or (2) not a share-based payment arrangement and therefore within the scope of other guidance. The guidance in ASU 2024-01 applies to all entities that issue profits interest awards as compensation to employees or non-employees in exchange for goods or services. We are currently evaluating the impacts of the improvements to our disclosure.

In March 2024, the Securities and Exchange Commission ("SEC") has released a final rule that requires registrants to provide comprehensive climate-related disclosures in their annual reports and registration statements, including those for IPOs, beginning with annual reports for the year ending December 31, 2027, for smaller reporting companies ("SRC"). Registrants must disclose climate-related financial metrics and impacts on their financial estimates and assumptions in a footnote to the audited financial statements. The disclosures will also need to be addressed as part of management’s internal control over financial reporting ("ICFR") and will be subject to the financial statement and ICFR audit (if applicable) of an independent registered public accounting firm. We are currently evaluating the impacts of the improvements to our disclosure.
v3.24.2
Revenue Recognition
9 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
The following table summarizes the contract balances recognized on the Company's consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Contract assets$23,061 $20,542 

Contract assets are included as part of the accounts receivable on the consolidated balances sheets. Contract liabilities had no balance as of June 30, 2024 and September 30, 2023.

Disaggregation of Revenue from Contracts with Customers

We disaggregate our revenue from contracts with customers by customer, contract type, as well as whether the Company acts as prime contractor or subcontractor. We believe these categories best depict how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. The following series of tables present our revenue disaggregated by these categories:

Revenue by customer was as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Department of Health and Human Services$48,301 $44,536 $139,937 $115,528 
Department of Veterans Affairs35,492 35,898 105,788 104,489 
Department of Defense15,175 21,003 48,458 50,802 
Other1,726 804 5,368 3,566 
Total $100,694 $102,241 $299,551 $274,385 
Revenue by contract type was as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Time and Materials$54,978 $51,572 $165,260 $154,366 
Cost Reimbursable19,513 29,110 60,166 58,951 
Firm Fixed Price26,203 21,559 74,125 61,068 
Total $100,694 $102,241 $299,551 $274,385 

Revenue by whether the Company acts as a prime contractor or a subcontractor was as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Prime Contractor$90,791 $97,885 $269,109 $259,692 
Subcontractor9,903 4,356 30,442 14,693 
Total $100,694 $102,241 $299,551 $274,385 
v3.24.2
Leases
9 Months Ended
Jun. 30, 2024
Leases [Abstract]  
Leases Leases
The following table summarizes lease balances presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Operating lease right-of-use assets$7,498 $9,656 
Operating lease liabilities, current$2,889 $3,463 
Operating lease liabilities - long-term13,521 15,908 
Total operating lease liabilities$16,410 $19,371 

As of June 30, 2024, operating leases for facilities and equipment have remaining lease terms of less than 1 year to 7.5 years.

Total lease costs for our leases were as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Operating $883 $1,097 $4,915 $2,921 
Short-term 50 83 298 225 
Variable 37 47 179 63 
Sublease income (a)(67)(71)(339)(214)
Total lease costs$903 $1,156 $5,053 $2,995 

(a) The Company subleases a portion of one of its leased facilities. The sublease is classified as an operating lease with respect to the underlying asset. The sublease term is 5 years and includes two additional 1 year term extension options.
The Company's future minimum lease payments as of June 30, 2024 were as follows (in thousands):
Fiscal year ending:
2024 (remaining)$1,108 
20253,572 
20263,350 
20272,751 
20282,602 
Thereafter6,546 
Total future lease payments19,929 
   Less: imputed interest(3,519)
Present value of future minimum lease payments16,410 
   Less: current portion of operating lease liabilities(2,889)
Long-term operating lease liabilities$13,521 
At June 30, 2024, the weighted-average remaining lease term and weighted-average discount rate were 6.0 years and 6.1%, respectively. The calculation of the weighted-average discount rate was determined based on borrowing terms from our secured term loan.

Other information related to our leases for the nine months ended June 30, 2024 and 2023 was as follows (in thousands):
20242023
Cash paid for amounts included in the measurement of lease liabilities$3,233 $3,317 
Lease liabilities arising from obtaining right-of-use assets— 2,052 
Other lease information$3,233 $5,369 
v3.24.2
Supporting Financial Information
9 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supporting Financial Information Supporting Financial Information
Accounts receivable

The following table summarizes accounts receivable presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Billed receivables$35,280 $38,577 
Contract assets23,061 20,542 
Accounts receivable$58,341 $59,119 
Other current assets

The following table summarizes other current assets presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Prepaid licenses and other expenses$1,426 $1,330 
Prepaid insurance and benefits856 743 
Other receivables460 994 
Other current assets$2,742 $3,067 
Goodwill

There were no activities in goodwill for the three and nine months ended June 30, 2024. The balance of goodwill was $138,161 as of June 30, 2024 and September 30, 2023.


Intangible assets

The following table summarizes intangible assets, net presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Intangible assets
Customer contracts and related customer relationships$113,622 $113,622 
Covenants not to compete637 637 
Trade name13,034 13,034 
Backlog37,249 37,249 
Total intangible assets164,542 164,542 
Less: accumulated amortization
Customer contracts and related customer relationships(38,455)(29,929)
Covenants not to compete(426)(378)
Trade name(3,162)(2,185)
Backlog(10,064)(7,273)
Total accumulated amortization(52,107)(39,765)
Intangible assets, net$112,435 $124,777 

Amortization expense was $4.1 million and $4.1 million for the three months ended June 30, 2024 and 2023, respectively, and $12.3 million and $10.7 million for the nine months ended June 30, 2024 and 2023, respectively.

As of June 30, 2024, the estimated amortization expense per fiscal year was as follows (in thousands):
Fiscal year ending:
2024 (remaining)$4,114 
202516,456 
202615,722 
202714,694 
202814,694 
Thereafter46,755 
Total amortization expense$112,435 

At June 30, 2024, the weighted-average remaining amortization period in total was 7.6 years. The weighted-average amortization period for customer contracts and related customer relationships, backlog, trade names and covenants not to
compete was 7.5 years, 7.8 years, 8.0 years, 5.6 years, respectively.

Equipment and improvements, net

The following table summarizes equipment and improvements, net presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Furniture and equipment$1,824 $1,790 
Computer equipment and software7,072 6,479 
Leasehold improvements1,614 1,614 
Total equipment and improvements10,510 9,883 
Less: accumulated depreciation
(8,720)(8,293)
Equipment and improvements, net$1,790 $1,590 

Depreciation expense was $0.2 million and $0.2 million for the three months ended June 30, 2024 and 2023, respectively; $0.4 million and $0.6 million for the nine months ended June 30, 2024 and 2023, respectively.

Accounts payable and accrued liabilities

The following table summarizes accounts payable and accrued liabilities presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Accounts payable$12,513 $12,603 
Accrued benefits5,111 6,414 
Accrued workers' compensation insurance1,828 2,369 
Accrued bonus and incentive compensation2,282 4,719 
Accrued interest1,241 1,309 
Other accrued expenses214 2,290 
Accounts payable and accrued liabilities$23,189 $29,704 

Accrued payroll

The following table summarizes accrued payroll presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Accrued leave$7,718 $9,621 
Accrued payroll5,277 2,487 
Accrued payroll taxes1,115 1,173 
Accrued severance122 513 
Total accrued payroll
$14,232 $13,794 
Debt obligations

The following table summarizes debt obligations presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Secured term loan$152,000 $169,813 
Secured revolving line of credit14,490 9,546 
Less: unamortized deferred financing costs(5,586)(7,024)
Net bank debt obligations160,904 172,335 
Less: current portion of debt obligations, net of deferred financing costs (a)(17,646)(17,188)
Long-term portion of debt obligations, net of deferred financing costs$143,258 $155,147 

As of June 30, 2024, we have satisfied quarterly minimum principal payments on our secured term loan through March 31, 2025.

(a) As of June 30, 2024, the current portion comprises term loan amortization of $4.8 million and the $14.5 million outstanding balance on the secured revolving line of credit, net of $1.6 million of unamortized deferred financing costs.
    
Interest expense

The following table summarizes interest expense presented on our consolidated statements of operations as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Interest expense (a)
$3,756 $4,282 $11,588 $9,972 
Interest income (b)
(10)— (34)— 
Amortization of deferred financing costs (c)
397 635 1,437 1,540 
Interest expense$4,143 $4,917 $12,991 $11,512 

(a) Interest expense on borrowing.
(b) Interest earned from customer payments received after the due date.
(c) Amortization of expenses related to secured term loan and secured revolving line of credit.
v3.24.2
Credit Facilities
9 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
Credit Facilities Credit Facilities
A summary of our credit facilities as presented on our consolidated balance sheets as follows (in millions):
June 30, 2024September 30, 2023
ArrangementLoan BalanceInterestArrangementLoan BalanceInterest
Secured term loan (a) due December 8, 2027$152,000 
SOFR1 + 4.1%
Secured term loan (a) due December 8, 2027$169,813 
SOFR1 + 4.1%
Secured revolving line of credit (b) due December 8, 2027$14,490 
SOFR1 + 4.1%
Secured revolving line of credit (b) due December 8, 2027$9,546 
SOFR1 + 4.1%
1Secured Overnight Financing Rate ("SOFR") as of June 30, 2024 and September 30, 2023 were 5.3% and 5.3% respectively.
(a) Represents the principal amounts payable on our term loan, which is secured by liens on substantially all of the assets of the Company. The principal of the term loan is payable in quarterly installments with the remaining balance due on December 8, 2027.
On January 31, 2023, we executed a floating-to-fixed interest rate swap with FNB which has a notional amount of $80.0 million at June 30, 2024, a fixed interest rate of 4.10% and a maturity date of January 31, 2026. As a result of entering these agreements, for the three and nine months ended June 30, 2024, interest expense has been decreased by approximately $0.3 million and $1.0 million, respectively.

The Credit Agreement requires compliance with a number of financial covenants and contains restrictions on our ability to engage in certain transactions. Among other matters, we must comply with limitations on: granting liens; incurring other indebtedness; maintenance of assets; investments in other entities and extensions of credit; mergers and consolidations; and changes in nature of business. The loan agreement also requires us to comply with certain quarterly financial covenants including: (i) a minimum fixed charge coverage ratio of at least 1.25 to 1.00, and (ii) a total leverage ratio not exceeding the ratio of 4.50:1.00 to 2.00:1.00 through maturity. The total leverage ratio is calculated by dividing the Company's total interest-bearing debt by net income adjusted to exclude (i) interest and other expenses, (ii) provision for income taxes (benefit) expense, if any, (iii) depreciation and amortization, and (iv) non-cash charges, losses or expenses, including stock-based compensation, and (v) non-recurring charges, losses or expenses to include transaction and non-cash equity expense. We are in compliance with all loan covenants and restrictions as of June 30, 2024 and September 30, 2023.

We are required to pay quarterly amortization payments, which commenced in December 2022. The annual amortization amounts are $14.3 million for fiscal year 2024, $19.0 million each for fiscal years 2025 and 2026, and $23.75 million for fiscal year 2027, with the remaining unpaid loan balance due at maturity in December 2027. The quarterly payments are equal installments. The Company made voluntary prepayments of $7.1 million during nine months ended June 30, 2024 bringing the outstanding principal balance on the secured term loan to $152.0 million. We have satisfied the mandatory principal payments through March 31, 2025.

In addition to quarterly payments of the outstanding indebtedness, the loan agreement also requires annual payments of a percentage of excess cash flow, as defined in the loan agreement. The loan agreement states that an excess cash flow recapture payment must be made equal to (a) 75% of the excess cash flow for the immediately preceding fiscal year in which indebtedness to consolidated EBITDA ratio is greater than or equal to 2.5:1; (b) 50% of the excess cash flow for the immediately preceding fiscal year in which the funded indebtedness to consolidated EBITDA Ratio is less than 2.5:1 but greater than or equal to 1.5:1; or (c) 0% of the excess cash flow for the immediately preceding fiscal year in which the funded indebtedness to consolidated EBITDA Ratio is less than 1.5:1. In addition, the Company must make additional mandatory prepayment of amounts outstanding based on proceeds received from asset sales and sales of certain equity securities or other indebtedness. Due to the voluntary prepayment of term debt, there was no excess cash flow payment required. For additional information regarding the schedule of future payment obligations, please refer to Note 10. Commitments and Contingencies.

(b) The secured revolving line of credit has a ceiling of up to $70.0 million; as of June 30, 2024, we had unused borrowing capacity of $24.0 million, which is net of outstanding letters of credit. Borrowing on the secured revolving line of credit is secured by liens on substantially all of the assets of the Company. The Company accessed funds from the secured revolving line of credit during the year, which had a $14.5 million outstanding balance at June 30, 2024. As part of the secured revolving line of credit, the lenders agreed to a sublimit of $10.0 million for letters of credit for the account of the Company, subject to applicable procedures.
v3.24.2
Stock-Based Compensation and Equity Grants
9 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation and Equity Grants Stock-Based Compensation and Equity Grants
Stock-based compensation expense
 
Options issued under equity incentive plans were designated as either an incentive stock or a non-statutory stock option. No option was granted with a term of more than 10 years from the date of grant. Exercisability of option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued shares. As of June 30, 2024, there were 0.9 million shares available for grant.
Stock-based compensation expense shown in the table below, is recorded in general and administrative expenses in our consolidated statements of operations as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
DLH employees (a)$537 $489 $1,851 $1,481 
Non-employee directors (b)180 179 439 539 
Total stock option expense$717 $668 $2,290 $2,020 

(a) Included in this amount are equity grants of restricted stock units ("RSU") to Executive Officers, which were issued in accordance with the DLH long-term incentive compensation policy in this fiscal year, including both RSU and stock option grants to employees during prior fiscal years. The RSUs issued and outstanding totaled 429,320 and 337,578 shares at June 30, 2024 and 2023, respectively. During the three months ended June 30, 2024 and 2023, there were no grants awarded to Executive Officers. For the nine months ended June 30, 2024 and 2023, the Company granted 169,544 and 197,174 shares of restricted stock units, respectively. During the nine months ended June 30, 2024, 84,773 shares of the RSUs granted have performance-based vesting criteria and the remaining 84,771 shares have service-based vesting criteria. During the nine months ended June 30, 2023, 141,892 shares of the RSUs granted have performance-based vesting criteria and the remaining 55,282 shares have service-based vesting criteria.

The RSUs granted during the nine months ended June 30, 2024 and 2023, were valued as follows using the Monte Carlo Method, and will be amortized over the 3-year measurement period.

(b) Equity grants of RSUs were made in accordance with DLH compensation policy for non-employee directors and a total of 61,525 and 50,367 restricted stock units were issued and outstanding at June 30, 2024 and 2023, respectively. These grants have service-based vesting criteria and vest at the end of this fiscal year.

The fair value of RSUs issued during the nine months ended June 30, 2024 and 2023 is presented in the table below:
Volatility
50%
Grant DatePerformance Vesting BasePerformance Vesting Criteria(Years)Fair Value
December 15, 2023RevenueRevenue increase at the end of the performance period as compared to the year ended September 30, 20233$3.82 
December 15, 2023Stock price
Stock price is at least $25.65 per share average for the 30 days prior to the end of the performance period
3$5.36 
January 27, 2023RevenueRevenue increase at the end of the performance period as compared to the year ended September 30, 20223$3.51 
January 27, 2023Stock price
Stock price is at least $33.21 per share average for the 30 days prior to the end of the performance period
3$2.92 
Notes:
Results based on 100,000 simulations
Unrecognized stock-based compensation expense

Unrecognized stock-based compensation expense is presented in the table below (in thousands):
June 30,
 20242023
Unrecognized expense for DLH employees (a)$6,119 $7,358 
Unrecognized expense for non-employee directors180 155 
Total unrecognized expense$6,299 $7,513 

(a) On a weighted average basis, the unrecognized expense as of June 30, 2024 is expected to be recognized within the next 3.17 years.

Stock option activity for the nine months ended June 30, 2024

The aggregate intrinsic value in the table below represents the total pretax intrinsic value (i.e., the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, times the number of shares) that would have been received by the option holders had all option holders exercised their in the money options on those dates. This amount will change based on the fair market value of the Company’s stock. A summary of the Company's stock option awards is as follows:
(in years)
Weighted
WeightedAverage(in thousands)
(in thousands)AverageRemainingAggregate
Number ofExerciseContractualIntrinsic
SharesPriceTermValue
Options outstanding, September 30, 2023
2,278 $8.40 5.80$8,693 
Granted— — — — 
Exercised
(535)5.03 — — 
Cancelled(75)11.66 — — 
Options outstanding, June 30, 2024
1,668 $8.94 5.70$7,370 
Vested and exercisable, June 30, 2024
1,408 $8.19 5.30$7,293 
Stock option shares outstanding, vested and unvested balance as follows (in thousands):
June 30,September 30,
20242023
Vested and exercisable1,408 1,608 
Unvested (a)260 670 
Options outstanding1,668 2,278 
(a) Certain awards vest upon satisfaction of certain performance criteria.
v3.24.2
Earnings Per Share
9 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
 
Basic earnings per share is calculated by dividing income available to common shareholders by the weighted average number of common shares outstanding and restricted stock grants that vested or are likely to vest during the period. Diluted earnings per share is calculated by dividing income available to common shareholders by the weighted average number of basic common shares outstanding, adjusted to reflect potentially dilutive securities. Diluted earnings per share is calculated using the treasury stock method.

Earnings per share information is presented in the table below (in thousands except for per share amounts):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Numerator:
Net income$1,139 $1,738 $5,102 $4,090 
Denominator:
Denominator for basic net income per share - weighted-average outstanding shares14,232 13,854 14,156 13,638 
Effect of dilutive securities:
Stock options and restricted stock472 685 560 783 
Denominator for diluted net income per share - weighted-average outstanding shares14,704 14,539 14,716 14,421 
Net income per share - basic$0.08 $0.13 $0.36 $0.30 
Net income per share - diluted$0.08 $0.12 $0.35 $0.28 
v3.24.2
Commitment and Contingencies
9 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Contractual obligations as of June 30, 2024 are as follows (in thousands):
  Payments Due Per Fiscal Year
 (Remaining)
Total20242025202620272028Thereafter
Debt obligations$166,490 $14,490 $9,500 $19,000 $23,750 $99,750 $— 
Facility operating leases19,929 1,108 3,572 3,350 2,751 2,602 6,546 
Total contractual obligations$186,419 $15,598 $13,072 $22,350 $26,501 $102,352 $6,546 

Legal proceedings

As a commercial enterprise and employer, the Company is subject to various claims and legal actions in the ordinary course of business. These matters can include professional liability, employment-relations issues, workers’ compensation, tax, payroll and employee-related matters, other commercial disputes arising in the course of its business, and inquiries and investigations by governmental agencies regarding our employment practices or other matters. The Company is not aware of any pending or threatened litigation that it believes is reasonably likely to have a material adverse effect on its results of operations, financial position or cash flows.
v3.24.2
Related Party Transactions
9 Months Ended
Jun. 30, 2024
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
The Company has determined that for the nine months ended June 30, 2024 and 2023, there were no significant related party transactions that have occurred which require disclosure through the date that these consolidated financial statements were issued.
v3.24.2
Subsequent Events
9 Months Ended
Jun. 30, 2024
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
Management has evaluated subsequent events through the date that the Company's unaudited consolidated financial statements were issued. Based on this evaluation, the Company has determined that no subsequent events have occurred which require disclosure through the date that these consolidated financial statements were issued.
v3.24.2
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.2
Significant Accounting Policies (Policies)
9 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Use of Estimates
Use of Estimates
 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The most significant of these estimates and assumptions relate to estimating costs including overhead and its allocation, valuing and determining the amortization periods for long-lived intangible assets, interest rate swaps, stock-based compensation, and right-of-use assets and lease liabilities. We evaluate these estimates and judgments on an ongoing basis and base our estimates on historical experience, current and expected future outcomes, third-party evaluations, and various other assumptions that we believe are reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities as well as identifying and assessing the accounting treatment with respect to commitments and contingencies. We revise material accounting estimates if changes occur, such as more experience is acquired, additional information is obtained, or there is new information on which an estimate was or can be based. Actual results could differ from those estimates.
Revenue
Revenue

The Company's revenues from contracts with customers are derived from offerings that include technology-enabled business process outsourcing, program management solutions, and public health research and analytics, substantially within the U.S. government and its agencies. The Company has various types of contracts including time-and-materials contracts, cost-reimbursable contracts, and firm-fixed-price contracts.

We consider a contract with a customer to exist when there is a commitment by both parties (customer and Company), payment terms are determinable, there is commercial substance, and collectability is probably in accordance with Accounting Standards Codification ("ASC") No. 606, "Revenue from Contracts with Customers" ("Topic 606").

We recognize revenue over time when there is a continuous transfer of control to our customer as performance obligations are satisfied. For our U.S. government contracts, this continuous transfer of control to the customer is transferred over time and revenue is recognized based on the extent of progress toward completion of the performance obligation. We consider control to transfer when we have a right to payment. In some instances, the Company commences providing services prior to formal approval to begin work from the customer. The Company considers these factors, the risks associated with commencing work, and legal enforceability in determining whether a contract exists under Topic 606.

Contract modification can occur throughout the life of the contract and can affect the transaction price, extend the period of performance, adjust funding, or create new performance obligations. We review each modification to assess the impact of these contract changes to determine if it should be treated as part of the original performance obligation or as a separate contract.
Contract modifications impact performance obligations when the modification either creates new or changes the existing enforceable rights and obligations. The effect of a contract modification on the transaction price and our measure of progress for the performance obligation to which it relates is recognized as an adjustment to revenue and profit cumulatively. Furthermore, a significant change in one or more estimates could affect the profitability of our contracts. We recognize adjustments in estimated profit on contracts in the period identified.

For service contracts, we satisfy our performance obligations as services are rendered. We use cost-based input and time-based output methods to measure progress based on the contract type.

Time and material - We bill the customer per labor hour and per material, and revenue is recognized in the amount invoiced as the amount corresponds directly to the value of our performance to date. Revenue is recognized to the extent of billable rates times hours delivered plus materials and other reimbursable costs incurred.
Cost reimbursable - We record reimbursable costs as incurred, including an estimated share of the contractual fee earned.
Firm fixed price - We recognize revenue over time using a straight-line measure of progress.

Contract costs generally include direct costs such as labor, materials, subcontract costs, and indirect costs identifiable with or allocable to a specific contract. Costs are expensed as incurred and include an estimate of the contractual fees earned. Contract costs incurred for U.S. government contracts, including indirect costs, are subject to audit and adjustment by various government audit agencies. Historically, our adjustments have not been material.

Contract assets - Amounts are invoiced as work progresses in accordance with agreed-upon contractual terms. In part, revenue recognition occurs before we have the right to bill, resulting in contract assets. These contract assets are reported within accounts receivable on our consolidated balance sheets and are invoiced in accordance with payment terms defined in each contract. Period end balances will vary from period to period due to agreed-upon contractual terms.
Disaggregation of Revenue from Contracts with Customers
We disaggregate our revenue from contracts with customers by customer, contract type, as well as whether the Company acts as prime contractor or subcontractor. We believe these categories best depict how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
 
The carrying amounts of the Company's cash, accounts receivable, contract assets, accrued expenses, and accounts payable approximate fair value due to the short-term nature of these instruments. The fair values of the Company's debt instruments approximate fair value because the underlying interest rates approximate market rates that the Company could obtain for similar instruments at the balance sheet dates.
Long-Lived Assets
Long-Lived Assets

Our long-lived assets include equipment and improvements, intangible assets, right-of-use assets, and goodwill. The Company continues to review long-lived assets for possible impairment or loss of value at least annually, or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit's carrying amount is greater than its fair value.

Equipment and improvements are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful asset lives (3 to 7 years) and the shorter of the initial lease term or estimated useful life for leasehold improvements. Maintenance and repair costs are expensed as incurred. Intangible assets (other than goodwill) are originally recorded at fair value and are amortized on a straight-line basis over their estimated useful lives of 10 years.
Right-of-Use Assets and Lease Liabilities
Right-of-use assets are measured at the present value of future minimum lease payments, including all probable renewals, plus lease payments made to the lessor before or at lease commencement and indirect costs paid, less incentives received. Our right-of-use assets include long-term leases for facilities and equipment and are amortized over their respective lease terms.
Lease Liabilities

The Company has leases for facilities and office equipment. Our lease liabilities are recognized as the present value of the future minimum lease payments over the lease term. Our lease payments consist of fixed and in-substance fixed amounts attributable to the use of the underlying asset over the lease term. Variable lease payments that do not depend on an index rate or are not in-substance fixed payments are excluded in the measurement of right-of-use assets and lease liabilities and are expensed in the period incurred. The incremental borrowing rate on our secured term loan is used in determining the present value of future minimum lease payments. Some of our lease agreements include options to extend the lease term or terminate the lease. These options are accounted for in our right-of-use assets and lease liabilities when it is reasonably certain that the Company will extend the lease term or terminate the lease. The Company does not have any finance leases.
Goodwill
Goodwill

The Company reviews goodwill for impairment on an annual basis and on a quarterly basis the Company assesses the impact of any macroeconomic changes that may impact the business conditions to determine if these changes have any adverse impact to goodwill. Notwithstanding this evaluation, factors including non-renewal of a major contract or other substantial changes in business conditions could have a material adverse effect on the valuation of goodwill in future periods and the resulting charge could be material to future periods’ results of operations. The Company determined that no change in business conditions occurred which would have a material adverse effect on the valuation of goodwill.
Income Tax
Income Tax
The Company accounts for income taxes in accordance with the asset and liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reflected on the consolidated balance sheets when it is determined that it is more likely than not that the asset will be realized. This guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax asset will not be realized. We account for uncertain tax positions by recognizing the financial statement effects of a tax position only when, based upon the technical merits, it is more likely than not that the position will be sustained upon examination.
Stock-based Compensation
Stock-Based Compensation

The Company uses the fair value-based method for stock-based compensation. Options issued are designated as either an incentive stock option or a non-statutory stock option. No option may be granted with a term of more than 10 years from the date of grant. Option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued common shares. All awards to employees and non-employees are recorded at fair value on the date of the grant and expensed over the period of vesting. The Company uses a Monte Carlo method to estimate the fair value of each stock option at the date of grant. Any consideration paid by the option holders to purchase shares is credited to common stock.

Stock-based compensation expense for the portion of equity awards for which the requisite service has not been rendered is recognized as the requisite service is rendered. The stock-based compensation expense for that portion of awards has been based on the grant-date fair value of those awards as calculated for recognition purposes under applicable guidance. For options that vest based on the Company’s common stock achieving and maintaining defined market prices, the Company values the awards with a Monte Carlo method that utilizes various probability factors and other criterion in establishing fair value of the grant. The related compensation expense is recognized over the service period.
Cash
Cash
The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. We maintain cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation up to $250,000. Deposits held with financial institutions may exceed the $250,000 limit.
Accounts Receivable
Accounts Receivable

Receivables include amounts billed and currently due from customers where the right to consideration is unconditional and amounts unbilled. Both billed and unbilled amounts are non-interest bearing, unsecured, and recognized at an estimated realizable value that includes costs and fees, and are generally expected to be billed and received within a single year. We evaluate our receivables for expected credit losses on a quarterly basis and determine whether an allowance for expected credit losses is appropriate based on specific collection issues.
Earnings Per Share
Earnings Per Share
Basic earnings per share is calculated by dividing income available to common shareholders by the weighted average number of common stock outstanding and restricted stock grants that vested or are likely to vest during the period. Diluted earnings per share is calculated by dividing income available to common shareholders by the weighted average number of basic common shares outstanding, adjusted to reflect potentially dilutive securities. Diluted earnings per share is calculated using the treasury stock method.
Treasury Stock and Preferred Stock
Treasury Stock

The Company periodically purchases its own common stock that is traded on public markets as part of announced stock repurchase programs. The repurchased common stock is classified as treasury stock on the consolidated balance sheets and held at cost. As of June 30, 2024 and September 30, 2023, the Company did not hold any treasury stock.

Preferred Stock
Our certificate of incorporation authorizes the issuance of "blank check" preferred stock with designations, rights and preferences as may be determined from time to time by our board of directors up to an aggregate of 5,000,000 shares of preferred stock.
Interest Rate Swap
Interest Rate Swap

The Company uses derivative financial instruments to manage interest rate risk associated with its variable debt. The Company's objective in using these interest rate derivatives is to manage its exposure to interest rate movements and reduce volatility of interest expense. The gains and losses due to changes in the fair value of the interest rate swap agreements completely offset changes in the fair value of the hedged portion of the underlying debt. Offsetting changes in fair value of both the interest rate swaps and the hedged portion of the underlying debt are recognized in interest expense in the consolidated statements of operations. The Company does not hold or issue any derivative instruments for trading or speculative purposes.
Risks and Uncertainties
Risks and Uncertainties

Management evaluates the impact of global markets and economic factors on our industry and the potential for adverse effects on the Company's consolidated financial position and its operations. As of June 30, 2024 and September 30, 2023 there was no indication of any global or economic impacts to our industry.
New Accounting Pronouncements New Accounting Pronouncements
In November 2023, Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" which provides guidance intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses, and each reported measure of segment profit or loss. The ASU requires that a public entity that has a single reportable segment provide all the disclosures required by the amendments in this ASU and all existing segment disclosures in Topic 280. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2023 and interim
periods beginning after December 15, 2024. We are currently evaluating the impacts of the single reportable segment disclosures.

In December 2023, FASB issued ASU 2023-09 "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" which provides guidance on the requirements such as the requirement that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. DLH is a public company that reports income tax disclosures and therefore this ASU applies to the Company. ASU 2023-09 is effective for public business entities for fiscal years beginning after Dec. 15, 2024. We are currently evaluating the impacts of the improvements to income tax disclosure.

In March 2024, FASB issued ASU No. 2024-01, "Scope Application of Profits Interest and Similar Awards". The ASU clarifies how an entity determines whether a profits interest or similar award is (1) within the scope of ASC 718 or (2) not a share-based payment arrangement and therefore within the scope of other guidance. The guidance in ASU 2024-01 applies to all entities that issue profits interest awards as compensation to employees or non-employees in exchange for goods or services. We are currently evaluating the impacts of the improvements to our disclosure.

In March 2024, the Securities and Exchange Commission ("SEC") has released a final rule that requires registrants to provide comprehensive climate-related disclosures in their annual reports and registration statements, including those for IPOs, beginning with annual reports for the year ending December 31, 2027, for smaller reporting companies ("SRC"). Registrants must disclose climate-related financial metrics and impacts on their financial estimates and assumptions in a footnote to the audited financial statements. The disclosures will also need to be addressed as part of management’s internal control over financial reporting ("ICFR") and will be subject to the financial statement and ICFR audit (if applicable) of an independent registered public accounting firm. We are currently evaluating the impacts of the improvements to our disclosure.
v3.24.2
Revenue Recognition (Tables)
9 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Contract Balances Recognized on the Company's Consolidated Balance Sheets
The following table summarizes the contract balances recognized on the Company's consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Contract assets$23,061 $20,542 
Schedule of Disaggregation of Revenue From Contracts with Customers The following series of tables present our revenue disaggregated by these categories:
Revenue by customer was as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Department of Health and Human Services$48,301 $44,536 $139,937 $115,528 
Department of Veterans Affairs35,492 35,898 105,788 104,489 
Department of Defense15,175 21,003 48,458 50,802 
Other1,726 804 5,368 3,566 
Total $100,694 $102,241 $299,551 $274,385 
Revenue by contract type was as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Time and Materials$54,978 $51,572 $165,260 $154,366 
Cost Reimbursable19,513 29,110 60,166 58,951 
Firm Fixed Price26,203 21,559 74,125 61,068 
Total $100,694 $102,241 $299,551 $274,385 

Revenue by whether the Company acts as a prime contractor or a subcontractor was as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Prime Contractor$90,791 $97,885 $269,109 $259,692 
Subcontractor9,903 4,356 30,442 14,693 
Total $100,694 $102,241 $299,551 $274,385 
v3.24.2
Leases (Tables)
9 Months Ended
Jun. 30, 2024
Leases [Abstract]  
Schedule of Summarized Lease Balances in Consolidated Balance Sheet The following table summarizes lease balances presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Operating lease right-of-use assets$7,498 $9,656 
Operating lease liabilities, current$2,889 $3,463 
Operating lease liabilities - long-term13,521 15,908 
Total operating lease liabilities$16,410 $19,371 
Schedule of Lease Costs and Other Information Related to Leases
Total lease costs for our leases were as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Operating $883 $1,097 $4,915 $2,921 
Short-term 50 83 298 225 
Variable 37 47 179 63 
Sublease income (a)(67)(71)(339)(214)
Total lease costs$903 $1,156 $5,053 $2,995 
Other information related to our leases for the nine months ended June 30, 2024 and 2023 was as follows (in thousands):
20242023
Cash paid for amounts included in the measurement of lease liabilities$3,233 $3,317 
Lease liabilities arising from obtaining right-of-use assets— 2,052 
Other lease information$3,233 $5,369 
Schedule of Company's Future Lease Payments
The Company's future minimum lease payments as of June 30, 2024 were as follows (in thousands):
Fiscal year ending:
2024 (remaining)$1,108 
20253,572 
20263,350 
20272,751 
20282,602 
Thereafter6,546 
Total future lease payments19,929 
   Less: imputed interest(3,519)
Present value of future minimum lease payments16,410 
   Less: current portion of operating lease liabilities(2,889)
Long-term operating lease liabilities$13,521 
v3.24.2
Supporting Financial Information (Tables)
9 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Accounts Receivable
The following table summarizes accounts receivable presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Billed receivables$35,280 $38,577 
Contract assets23,061 20,542 
Accounts receivable$58,341 $59,119 
Schedule of Other Current Assets
The following table summarizes other current assets presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Prepaid licenses and other expenses$1,426 $1,330 
Prepaid insurance and benefits856 743 
Other receivables460 994 
Other current assets$2,742 $3,067 
Schedule of Intangible Assets
The following table summarizes intangible assets, net presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Intangible assets
Customer contracts and related customer relationships$113,622 $113,622 
Covenants not to compete637 637 
Trade name13,034 13,034 
Backlog37,249 37,249 
Total intangible assets164,542 164,542 
Less: accumulated amortization
Customer contracts and related customer relationships(38,455)(29,929)
Covenants not to compete(426)(378)
Trade name(3,162)(2,185)
Backlog(10,064)(7,273)
Total accumulated amortization(52,107)(39,765)
Intangible assets, net$112,435 $124,777 
Schedule of Estimated Amortization of Intangible Assets
As of June 30, 2024, the estimated amortization expense per fiscal year was as follows (in thousands):
Fiscal year ending:
2024 (remaining)$4,114 
202516,456 
202615,722 
202714,694 
202814,694 
Thereafter46,755 
Total amortization expense$112,435 
Schedule of Equipment and Improvements, Net
The following table summarizes equipment and improvements, net presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Furniture and equipment$1,824 $1,790 
Computer equipment and software7,072 6,479 
Leasehold improvements1,614 1,614 
Total equipment and improvements10,510 9,883 
Less: accumulated depreciation
(8,720)(8,293)
Equipment and improvements, net$1,790 $1,590 
Schedule of Accounts Payable, Accrued Expenses, and Other Current Liabilities
The following table summarizes accounts payable and accrued liabilities presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Accounts payable$12,513 $12,603 
Accrued benefits5,111 6,414 
Accrued workers' compensation insurance1,828 2,369 
Accrued bonus and incentive compensation2,282 4,719 
Accrued interest1,241 1,309 
Other accrued expenses214 2,290 
Accounts payable and accrued liabilities$23,189 $29,704 
Schedule of Accrued Payroll
The following table summarizes accrued payroll presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Accrued leave$7,718 $9,621 
Accrued payroll5,277 2,487 
Accrued payroll taxes1,115 1,173 
Accrued severance122 513 
Total accrued payroll
$14,232 $13,794 
Schedule of Debt Obligations
The following table summarizes debt obligations presented on our consolidated balance sheets as follows (in thousands):
June 30,September 30,
20242023
Secured term loan$152,000 $169,813 
Secured revolving line of credit14,490 9,546 
Less: unamortized deferred financing costs(5,586)(7,024)
Net bank debt obligations160,904 172,335 
Less: current portion of debt obligations, net of deferred financing costs (a)(17,646)(17,188)
Long-term portion of debt obligations, net of deferred financing costs$143,258 $155,147 

As of June 30, 2024, we have satisfied quarterly minimum principal payments on our secured term loan through March 31, 2025.

(a) As of June 30, 2024, the current portion comprises term loan amortization of $4.8 million and the $14.5 million outstanding balance on the secured revolving line of credit, net of $1.6 million of unamortized deferred financing costs.
Schedule of Interest Expense
The following table summarizes interest expense presented on our consolidated statements of operations as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Interest expense (a)
$3,756 $4,282 $11,588 $9,972 
Interest income (b)
(10)— (34)— 
Amortization of deferred financing costs (c)
397 635 1,437 1,540 
Interest expense$4,143 $4,917 $12,991 $11,512 

(a) Interest expense on borrowing.
(b) Interest earned from customer payments received after the due date.
(c) Amortization of expenses related to secured term loan and secured revolving line of credit.
v3.24.2
Credit Facilities (Tables)
9 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
Summary of Credit Facilities
A summary of our credit facilities as presented on our consolidated balance sheets as follows (in millions):
June 30, 2024September 30, 2023
ArrangementLoan BalanceInterestArrangementLoan BalanceInterest
Secured term loan (a) due December 8, 2027$152,000 
SOFR1 + 4.1%
Secured term loan (a) due December 8, 2027$169,813 
SOFR1 + 4.1%
Secured revolving line of credit (b) due December 8, 2027$14,490 
SOFR1 + 4.1%
Secured revolving line of credit (b) due December 8, 2027$9,546 
SOFR1 + 4.1%
1Secured Overnight Financing Rate ("SOFR") as of June 30, 2024 and September 30, 2023 were 5.3% and 5.3% respectively.
v3.24.2
Stock-Based Compensation and Equity Grants (Tables)
9 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
Stock-based compensation expense shown in the table below, is recorded in general and administrative expenses in our consolidated statements of operations as follows (in thousands):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
DLH employees (a)$537 $489 $1,851 $1,481 
Non-employee directors (b)180 179 439 539 
Total stock option expense$717 $668 $2,290 $2,020 

(a) Included in this amount are equity grants of restricted stock units ("RSU") to Executive Officers, which were issued in accordance with the DLH long-term incentive compensation policy in this fiscal year, including both RSU and stock option grants to employees during prior fiscal years. The RSUs issued and outstanding totaled 429,320 and 337,578 shares at June 30, 2024 and 2023, respectively. During the three months ended June 30, 2024 and 2023, there were no grants awarded to Executive Officers. For the nine months ended June 30, 2024 and 2023, the Company granted 169,544 and 197,174 shares of restricted stock units, respectively. During the nine months ended June 30, 2024, 84,773 shares of the RSUs granted have performance-based vesting criteria and the remaining 84,771 shares have service-based vesting criteria. During the nine months ended June 30, 2023, 141,892 shares of the RSUs granted have performance-based vesting criteria and the remaining 55,282 shares have service-based vesting criteria.

The RSUs granted during the nine months ended June 30, 2024 and 2023, were valued as follows using the Monte Carlo Method, and will be amortized over the 3-year measurement period.

(b) Equity grants of RSUs were made in accordance with DLH compensation policy for non-employee directors and a total of 61,525 and 50,367 restricted stock units were issued and outstanding at June 30, 2024 and 2023, respectively. These grants have service-based vesting criteria and vest at the end of this fiscal year.
Unrecognized stock-based compensation expense is presented in the table below (in thousands):
June 30,
 20242023
Unrecognized expense for DLH employees (a)$6,119 $7,358 
Unrecognized expense for non-employee directors180 155 
Total unrecognized expense$6,299 $7,513 

(a) On a weighted average basis, the unrecognized expense as of June 30, 2024 is expected to be recognized within the next 3.17 years.
Summary of Performance Vesting Critera
The fair value of RSUs issued during the nine months ended June 30, 2024 and 2023 is presented in the table below:
Volatility
50%
Grant DatePerformance Vesting BasePerformance Vesting Criteria(Years)Fair Value
December 15, 2023RevenueRevenue increase at the end of the performance period as compared to the year ended September 30, 20233$3.82 
December 15, 2023Stock price
Stock price is at least $25.65 per share average for the 30 days prior to the end of the performance period
3$5.36 
January 27, 2023RevenueRevenue increase at the end of the performance period as compared to the year ended September 30, 20223$3.51 
January 27, 2023Stock price
Stock price is at least $33.21 per share average for the 30 days prior to the end of the performance period
3$2.92 
Notes:
Results based on 100,000 simulations
Schedule of Stock Option Activity A summary of the Company's stock option awards is as follows:
(in years)
Weighted
WeightedAverage(in thousands)
(in thousands)AverageRemainingAggregate
Number ofExerciseContractualIntrinsic
SharesPriceTermValue
Options outstanding, September 30, 2023
2,278 $8.40 5.80$8,693 
Granted— — — — 
Exercised
(535)5.03 — — 
Cancelled(75)11.66 — — 
Options outstanding, June 30, 2024
1,668 $8.94 5.70$7,370 
Vested and exercisable, June 30, 2024
1,408 $8.19 5.30$7,293 
Schedule of Option Shares Outstanding, Vested and Expected to Vest
Stock option shares outstanding, vested and unvested balance as follows (in thousands):
June 30,September 30,
20242023
Vested and exercisable1,408 1,608 
Unvested (a)260 670 
Options outstanding1,668 2,278 
(a) Certain awards vest upon satisfaction of certain performance criteria.
v3.24.2
Earnings Per Share (Tables)
9 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Diluted Earnings per Share
Earnings per share information is presented in the table below (in thousands except for per share amounts):
Three Months EndedNine Months Ended
June 30,June 30,
2024202320242023
Numerator:
Net income$1,139 $1,738 $5,102 $4,090 
Denominator:
Denominator for basic net income per share - weighted-average outstanding shares14,232 13,854 14,156 13,638 
Effect of dilutive securities:
Stock options and restricted stock472 685 560 783 
Denominator for diluted net income per share - weighted-average outstanding shares14,704 14,539 14,716 14,421 
Net income per share - basic$0.08 $0.13 $0.36 $0.30 
Net income per share - diluted$0.08 $0.12 $0.35 $0.28 
v3.24.2
Commitment and Contingencies (Tables)
9 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Contractual Obligations
Contractual obligations as of June 30, 2024 are as follows (in thousands):
  Payments Due Per Fiscal Year
 (Remaining)
Total20242025202620272028Thereafter
Debt obligations$166,490 $14,490 $9,500 $19,000 $23,750 $99,750 $— 
Facility operating leases19,929 1,108 3,572 3,350 2,751 2,602 6,546 
Total contractual obligations$186,419 $15,598 $13,072 $22,350 $26,501 $102,352 $6,546 
v3.24.2
Significant Accounting Policies (Details) - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Sep. 30, 2023
Acquired Indefinite-lived Intangible Assets [Line Items]      
Estimated useful live of intangible assets 10 years    
Uncertain tax positions $ 0   $ 0
Income tax interest expense 0 $ 0  
Income tax penalties expense 0 $ 0  
Cash, FDIC insured amount $ 250    
Treasury stock held (in shares) 0   0
Preferred shares authorized (in shares) 5,000,000    
Preferred stock issued (in shares) 0   0
Employee Stock Option | Omnibus Equity Incentive Plan 2016      
Acquired Indefinite-lived Intangible Assets [Line Items]      
Expiration term of share-based compensation plan awards 10 years    
Minimum      
Acquired Indefinite-lived Intangible Assets [Line Items]      
Estimated useful of long-lived assets 3 years    
Maximum      
Acquired Indefinite-lived Intangible Assets [Line Items]      
Estimated useful of long-lived assets 7 years    
v3.24.2
Revenue Recognition - Contract Balances (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]    
Contract assets $ 23,061 $ 20,542
v3.24.2
Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]    
Contract liabilities $ 0.0 $ 0.0
v3.24.2
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Disaggregation of Revenue [Line Items]        
Total $ 100,694 $ 102,241 $ 299,551 $ 274,385
Prime Contractor        
Disaggregation of Revenue [Line Items]        
Total 90,791 97,885 269,109 259,692
Subcontractor        
Disaggregation of Revenue [Line Items]        
Total 9,903 4,356 30,442 14,693
Time and Materials        
Disaggregation of Revenue [Line Items]        
Total 54,978 51,572 165,260 154,366
Cost Reimbursable        
Disaggregation of Revenue [Line Items]        
Total 19,513 29,110 60,166 58,951
Firm Fixed Price        
Disaggregation of Revenue [Line Items]        
Total 26,203 21,559 74,125 61,068
Department of Health and Human Services | Revenue from Contract with Customer | Customer concentration        
Disaggregation of Revenue [Line Items]        
Total 48,301 44,536 139,937 115,528
Department of Veterans Affairs | Revenue from Contract with Customer | Customer concentration        
Disaggregation of Revenue [Line Items]        
Total 35,492 35,898 105,788 104,489
Department of Defense | Revenue from Contract with Customer | Customer concentration        
Disaggregation of Revenue [Line Items]        
Total 15,175 21,003 48,458 50,802
Other | Revenue from Contract with Customer | Customer concentration        
Disaggregation of Revenue [Line Items]        
Total $ 1,726 $ 804 $ 5,368 $ 3,566
v3.24.2
Leases - Summary of Lease Balances in Consolidated Balance Sheets (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Leases [Abstract]    
Operating lease right-of-use assets $ 7,498 $ 9,656
Operating lease liabilities - current 2,889 3,463
Operating lease liabilities - long-term 13,521 15,908
Total operating lease liabilities $ 16,410 $ 19,371
v3.24.2
Leases - Narrative (Details)
9 Months Ended
Jun. 30, 2024
sublease
sublease_option
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Number of facilities subleased | sublease 1
Sublease term 5 years
Sublease number of additional extension options | sublease_option 2
Sublease extension option period 1 year
Weighted-average remaining lease term 6 years
Weighted-average discount rate 6.10%
Minimum | Facilities and Equipment  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Operating lease term (in years) 1 year
Maximum | Facilities and Equipment  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Operating lease term (in years) 7 years 6 months
v3.24.2
Leases - Lease Costs (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Leases [Abstract]        
Operating $ 883 $ 1,097 $ 4,915 $ 2,921
Short-term 50 83 298 225
Variable 37 47 179 63
Sublease income (67) (71) (339) (214)
Total lease costs $ 903 $ 1,156 $ 5,053 $ 2,995
v3.24.2
Leases - Company's Future Minimum Lease Payments (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Leases [Abstract]    
2024 (remaining) $ 1,108  
2025 3,572  
2026 3,350  
2027 2,751  
2028 2,602  
Thereafter 6,546  
Total future lease payments 19,929  
Less: imputed interest (3,519)  
Total operating lease liabilities 16,410 $ 19,371
Less: current portion of operating lease liabilities (2,889) (3,463)
Long-term operating lease liabilities $ 13,521 $ 15,908
v3.24.2
Leases - Other Information Related to Leases (Details) - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Leases [Abstract]    
Cash paid for amounts included in the measurement of lease liabilities $ 3,233 $ 3,317
Lease liabilities arising from obtaining right-of-use assets 0 2,052
Other lease information $ 3,233 $ 5,369
v3.24.2
Supporting Financial Information - Accounts Receivable (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Billed receivables $ 35,280 $ 38,577
Contract assets 23,061 20,542
Accounts receivable $ 58,341 $ 59,119
v3.24.2
Supporting Financial Information - Other Current Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Prepaid licenses and other expenses $ 1,426 $ 1,330
Prepaid insurance and benefits 856 743
Other receivables 460 994
Other current assets $ 2,742 $ 3,067
v3.24.2
Supporting Financial Information - Goodwill (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Goodwill, Period Increase (Decrease) $ 0 $ 0  
Goodwill $ 138,161 $ 138,161 $ 138,161
v3.24.2
Supporting Financial Information - Intangible Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Finite-Lived Intangible Assets [Line Items]    
Total intangible assets $ 164,542 $ 164,542
Total accumulated amortization (52,107) (39,765)
Intangible assets, net 112,435 124,777
Customer contracts and related customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Total intangible assets 113,622 113,622
Total accumulated amortization (38,455) (29,929)
Covenants not to compete    
Finite-Lived Intangible Assets [Line Items]    
Total intangible assets 637 637
Total accumulated amortization (426) (378)
Trade name    
Finite-Lived Intangible Assets [Line Items]    
Total intangible assets 13,034 13,034
Total accumulated amortization (3,162) (2,185)
Backlog    
Finite-Lived Intangible Assets [Line Items]    
Total intangible assets 37,249 37,249
Total accumulated amortization $ (10,064) $ (7,273)
v3.24.2
Supporting Financial Information - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Finite-Lived Intangible Assets [Line Items]        
Amortization expense of intangible assets $ 4.1 $ 4.1 $ 12.3 $ 10.7
Intangible assets, remaining amortization period 7 years 7 months 6 days   7 years 7 months 6 days  
Depreciation $ 0.2 $ 0.2 $ 0.4 $ 0.6
Customer contracts and related customer relationships        
Finite-Lived Intangible Assets [Line Items]        
Intangible assets, remaining amortization period 7 years 6 months   7 years 6 months  
Backlog        
Finite-Lived Intangible Assets [Line Items]        
Intangible assets, remaining amortization period 7 years 9 months 18 days   7 years 9 months 18 days  
Trade name        
Finite-Lived Intangible Assets [Line Items]        
Intangible assets, remaining amortization period 8 years   8 years  
Covenants not to compete        
Finite-Lived Intangible Assets [Line Items]        
Intangible assets, remaining amortization period 5 years 7 months 6 days   5 years 7 months 6 days  
v3.24.2
Supporting Financial Information - Estimated Future Amortization Expense of Intangible Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
2024 (remaining) $ 4,114  
2025 16,456  
2026 15,722  
2027 14,694  
2028 14,694  
Thereafter 46,755  
Intangible assets, net $ 112,435 $ 124,777
v3.24.2
Supporting Financial Information - Equipment and Improvements, Net (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Furniture and equipment $ 1,824 $ 1,790
Computer equipment and software 7,072 6,479
Leasehold improvements 1,614 1,614
Total equipment and improvements 10,510 9,883
Less: accumulated depreciation (8,720) (8,293)
Equipment and improvements, net $ 1,790 $ 1,590
v3.24.2
Supporting Financial Information - Accounts Payable, Accrued Expense and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accounts payable $ 12,513 $ 12,603
Accrued benefits 5,111 6,414
Accrued workers' compensation insurance 1,828 2,369
Accrued bonus and incentive compensation 2,282 4,719
Accrued interest 1,241 1,309
Other accrued expenses 214 2,290
Accounts payable and accrued liabilities $ 23,189 $ 29,704
v3.24.2
Supporting Financial Information - Accrued Payroll (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued leave $ 7,718 $ 9,621
Accrued payroll 5,277 2,487
Accrued payroll taxes 1,115 1,173
Accrued severance 122 513
Total accrued payroll $ 14,232 $ 13,794
v3.24.2
Supporting Financial Information - Debt Obligations (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Sep. 30, 2023
Debt Instrument [Line Items]    
Long-term debt $ 166,490  
Net bank debt obligations 160,904 $ 172,335
Less: current portion of debt obligations, net of deferred financing costs (a) (17,646) (17,188)
Long-term portion of debt obligations, net of deferred financing costs 143,258 155,147
Debt amortization fiscal year 2025 9,500  
Secured Debt    
Debt Instrument [Line Items]    
Long-term debt 152,000 169,813
Less: unamortized deferred financing costs (5,586) (7,024)
Debt amortization fiscal year 2025 4,800  
Current unamortized deferred financing costs 1,600  
Revolving Line of Credit    
Debt Instrument [Line Items]    
Long-term debt 14,490 9,546
Revolving Line of Credit | Secured Debt    
Debt Instrument [Line Items]    
Long-term debt $ 14,490 $ 9,546
v3.24.2
Supporting Financial Information - Interest Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Interest expense $ 3,756 $ 4,282 $ 11,588 $ 9,972
Interest income (10) 0 (34) 0
Amortization of deferred financing costs 397 635 1,437 1,540
Interest expense $ 4,143 $ 4,917 $ 12,991 $ 11,512
v3.24.2
Credit Facilities - Schedule of Credit Facilities (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Jun. 30, 2024
Sep. 30, 2023
Line of Credit Facility [Line Items]    
Long-term debt $ 166,490  
Interest rate spread 5.30% 5.30%
Revolving Line of Credit    
Line of Credit Facility [Line Items]    
Long-term debt $ 14,490 $ 9,546
Secured Debt    
Line of Credit Facility [Line Items]    
Long-term debt 152,000 169,813
Secured Debt | Term Loans    
Line of Credit Facility [Line Items]    
Long-term debt $ 152,000 $ 169,813
Interest 4.10% 4.10%
Secured Debt | Revolving Line of Credit    
Line of Credit Facility [Line Items]    
Long-term debt $ 14,490 $ 9,546
Interest 4.10% 4.10%
v3.24.2
Credit Facilities - Narrative (Details)
3 Months Ended 9 Months Ended
Jun. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Line of Credit Facility [Line Items]      
Debt amortization fiscal year 2024 $ 14,490,000 $ 14,490,000  
Debt amortization fiscal year 2025 9,500,000 9,500,000  
Debt amortization fiscal year 2026 19,000,000 19,000,000  
Debt amortization fiscal year 2027 23,750,000 23,750,000  
Long-term debt 166,490,000 166,490,000  
Interest Rate Swap Due 2026      
Line of Credit Facility [Line Items]      
Derivative notional amount $ 80,000,000 $ 80,000,000  
Derivative fixed interest rate 4.10% 4.10%  
Interest Rate Swap      
Line of Credit Facility [Line Items]      
Decrease in interest expense $ 300,000 $ 1,000,000  
Revolving Line of Credit      
Line of Credit Facility [Line Items]      
Long-term debt 14,490,000 14,490,000 $ 9,546,000
Secured Debt      
Line of Credit Facility [Line Items]      
Debt amortization fiscal year 2025 4,800,000 4,800,000  
Long-term debt 152,000,000 $ 152,000,000 169,813,000
Secured Debt | Term Loans      
Line of Credit Facility [Line Items]      
Fixed charge coverage ratio   1.25  
Debt amortization fiscal year 2024 14,300,000 $ 14,300,000  
Debt amortization fiscal year 2025 19,000,000 19,000,000  
Debt amortization fiscal year 2026 19,000,000 19,000,000  
Debt amortization fiscal year 2027 23,750,000 23,750,000  
Voluntary principal amortization of term debt   7,100,000  
Long-term debt 152,000,000 $ 152,000,000 169,813,000
Secured Debt | Term Loans | Excess Cash Flows Greater Than Or Equal to 2.50      
Line of Credit Facility [Line Items]      
Percentage of excess cash flow for each year of funded indebtedness to EBDTA   75.00%  
Ratio of funded indebtedness to adjusted EBIDTA   2.5  
Secured Debt | Term Loans | Excess Cash Flows Less Than 2.50 But Greater Than 1.50      
Line of Credit Facility [Line Items]      
Percentage of excess cash flow for each year of funded indebtedness to EBDTA   50.00%  
Secured Debt | Term Loans | Excess Cash Flows Less Than 2.50      
Line of Credit Facility [Line Items]      
Ratio of funded indebtedness to adjusted EBIDTA   2.5  
Secured Debt | Term Loans | Excess Cash Flows Equal to 1.50      
Line of Credit Facility [Line Items]      
Ratio of funded indebtedness to adjusted EBIDTA   1.5  
Secured Debt | Term Loans | Excess Cash Flows Less Than 1.50      
Line of Credit Facility [Line Items]      
Percentage of excess cash flow for each year of funded indebtedness to EBDTA   0.00%  
Ratio of funded indebtedness to adjusted EBIDTA   1.5  
Secured Debt | Term Loans | Maximum      
Line of Credit Facility [Line Items]      
Ratio of funded indebtedness to EBITDA through maturity   4.50  
Secured Debt | Term Loans | Minimum      
Line of Credit Facility [Line Items]      
Ratio of funded indebtedness to EBITDA through maturity   2.00  
Secured Debt | Revolving Line of Credit      
Line of Credit Facility [Line Items]      
Long-term debt 14,490,000 $ 14,490,000 $ 9,546,000
Line of credit, maximum borrowing capacity 70,000,000 70,000,000  
Line of credit, unused borrowing capacity 24,000,000 24,000,000  
Secured Debt | Letter of Credit      
Line of Credit Facility [Line Items]      
Line of credit, current borrowing capacity $ 10,000,000 $ 10,000,000  
v3.24.2
Stock-Based Compensation and Equity Grants - Narrative (Details) - shares
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Omnibus Equity Incentive Plan 2016        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares available for grant (in shares) 900,000   900,000  
Employee Stock Option | Omnibus Equity Incentive Plan 2016        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expiration term of share-based compensation plan awards     10 years  
Restricted Stock Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of restricted stock units granted (in shares)     429,320 337,578
Restricted Stock Units | NEO        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of restricted stock units granted (in shares) 0 0 169,544 197,174
Performance Shares | NEO        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of restricted stock units granted (in shares)     84,773 141,892
Service Based Restricted Stock Units | NEO        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of restricted stock units granted (in shares)     84,771 55,282
v3.24.2
Stock-Based Compensation and Equity Grants - Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock option expense $ 717 $ 668 $ 2,290 $ 2,020
Total unrecognized expense 6,299 7,513 $ 6,299 $ 7,513
Restricted Stock Units        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Number of restricted stock units granted (in shares)     429,320 337,578
Expected term (years)     3 years  
DLH employees        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total unrecognized expense 6,119 7,358 $ 6,119 $ 7,358
Weighted average share based compensation expense recognition period     3 years 2 months 1 day  
Non-employee directors        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total unrecognized expense $ 180 $ 155 $ 180 $ 155
Non-employee directors | Restricted Stock Units        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Number of restricted stock units granted (in shares) 61,525 50,367    
NEO | Restricted Stock Units        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Number of restricted stock units granted (in shares) 0 0 169,544 197,174
NEO | Performance Shares        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Number of restricted stock units granted (in shares)     84,773 141,892
NEO | Service Based Restricted Stock Units        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Number of restricted stock units granted (in shares)     84,771 55,282
Selling, General and Administrative Expenses | DLH employees        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock option expense $ 537 $ 489 $ 1,851 $ 1,481
Selling, General and Administrative Expenses | Non-employee directors        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock option expense $ 180 $ 179 $ 439 $ 539
v3.24.2
Stock-Based Compensation and Equity Grants - FV of Performance Based Awards (Details) - $ / shares
9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Volatility 50.00% 50.00%
December 15, 2023    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Minimum average price (in dollars per share) $ 25.65 $ 25.65
January 27, 2023    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Minimum average price (in dollars per share) $ 33.21 $ 33.21
Revenue | December 15, 2023    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected term (years) 3 years 3 years
Calculated fair value (in dollars per share) $ 3.82 $ 3.82
Revenue | January 27, 2023    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected term (years) 3 years 3 years
Calculated fair value (in dollars per share) $ 3.51 $ 3.51
Stock price | December 15, 2023    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected term (years) 3 years 3 years
Calculated fair value (in dollars per share) $ 5.36 $ 5.36
Stock price | January 27, 2023    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected term (years) 3 years 3 years
Calculated fair value (in dollars per share) $ 2.92 $ 2.92
v3.24.2
Stock-Based Compensation and Equity Grants - Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
9 Months Ended 12 Months Ended
Jun. 30, 2024
Sep. 30, 2023
Number of Shares    
Options outstanding, beginning (in shares) 2,278  
Granted (in shares) 0  
Exercised (in shares) (535)  
Cancelled (in shares) (75)  
Options outstanding, ending (in shares) 1,668 2,278
Weighted Average Exercise Price    
Options outstanding, beginning (in dollars per share) $ 8.40  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 5.03  
Cancelled (in dollars per share) 11.66  
Options outstanding, ending (in dollars per share) $ 8.94 $ 8.40
Weighted Average Remaining Contractual Term    
Weighted Average Remaining Contractual Term 5 years 8 months 12 days 5 years 9 months 18 days
Aggregate Intrinsic Value    
Aggregate Intrinsic Value $ 7,370 $ 8,693
Vested and exercisable (in shares) 1,408  
Vested and exercisable, weighted average exercise price (in dollars per share) $ 8.19  
Vested and exercisable, weighted average remaining contractual term (in years) 5 years 3 months 18 days  
Vested and exercisable, intrinsic value $ 7,293  
v3.24.2
Stock-Based Compensation and Equity Grants - Stock Options Outstanding, Vested and Unvested (Details) - shares
shares in Thousands
Jun. 30, 2024
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]    
Vested and exercisable (in shares) 1,408 1,608
Unvested (in shares) 260 670
Option outstanding (in shares) 1,668 2,278
v3.24.2
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Numerator:        
Net income $ 1,139 $ 1,738 $ 5,102 $ 4,090
Denominator:        
Denominator for basic net income (loss) per share - weighted-average outstanding shares (in shares) 14,232 13,854 14,156 13,638
Effect of dilutive securities:        
Stock options and restricted stock (in shares) 472 685 560 783
Denominator for diluted net income (loss) per share - weighted-average outstanding shares (in shares) 14,704 14,539 14,716 14,421
Net income per share - basic (in dollars per share) $ 0.08 $ 0.13 $ 0.36 $ 0.30
Net income per share - diluted (in dollars per share) $ 0.08 $ 0.12 $ 0.35 $ 0.28
v3.24.2
Commitments and Contingencies - Contractual Obligations (Details)
$ in Thousands
Jun. 30, 2024
USD ($)
Debt obligations  
Debt obligations $ 166,490
2024 14,490
2025 9,500
2026 19,000
2027 23,750
2028 99,750
Thereafter 0
Operating Leases  
Total future lease payments 19,929
2024 (remaining) 1,108
2025 3,572
2026 3,350
2027 2,751
2028 2,602
Thereafter 6,546
Total Contractual Obligations  
Total Obligations 186,419
2024 15,598
2025 13,072
2026 22,350
2027 26,501
2028 102,352
Thereafter 6,546
Facility operating leases  
Operating Leases  
Total future lease payments 19,929
2024 (remaining) 1,108
2025 3,572
2026 3,350
2027 2,751
2028 2,602
Thereafter $ 6,546

DLH (NASDAQ:DLHC)
過去 株価チャート
から 7 2024 まで 8 2024 DLHのチャートをもっと見るにはこちらをクリック
DLH (NASDAQ:DLHC)
過去 株価チャート
から 8 2023 まで 8 2024 DLHのチャートをもっと見るにはこちらをクリック